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ABSTRACT: Although low-density lipoprotein (LDL) receptor-mediated cholesterol uptake through clathrincoated pits is now well understood, the molecular details and organizing principles for selective cholesterol
uptake/efflux (reverse cholesterol transport, RCT) from peripheral cells remain to be resolved. It is not
yet completely clear whether RCT between serum lipoproteins and the plasma membrane occurs primarily
through lipid rafts/caveolae or from non-raft domains. To begin to address these issues, lipid raft/caveolae-,
caveolae-, and non-raft-enriched fractions were resolved from purified plasma membranes isolated from
L-cell fibroblasts and MDCK cells by detergent-free affinity chromatography and compared with detergentresistant membranes isolated from the same cells. Fluorescent sterol exchange assays between lipoproteins
(VLDL, LDL, HDL, apoA1) and these enriched domains provided new insights into supporting the role
of lipid rafts/caveolae and caveolae in plasma membrane/lipoprotein cholesterol dynamics: (i) lipids known
to be translocated through caveolae were detected (cholesteryl ester, triacylglycerol) and/or enriched
(cholesterol, phospholipid) in lipid raft/caveolae fractions; (ii) lipoprotein-mediated sterol uptake/efflux
from lipid rafts/caveolae and caveolae was rapid and lipoprotein specific, whereas that from non-rafts
was very slow and independent of lipoprotein class; and (iii) the rate and lipoprotein specificity of sterol
efflux from lipid rafts/caveolae or caveolae to lipoprotein acceptors in Vitro was slower and differed in
specificity from that in intact cellssconsistent with intracellular factors contributing significantly to
cholesterol dynamics between the plasma membrane and lipoproteins.

Cellular cholesterol homeostasis involves a balance of
cholesterol uptake (dietary and de noVo synthesized), intracellular storage, and efflux. Although cholesterol is an
essential component of membranes and a precursor of
steroids, excess cholesterol is associated with diabetic
complications, atherosclerosis, cardiovascular disease, and
other diseases. Since intracellular storage of cholesterol in
esterified form is limited in peripheral tissues, mammals have
evolved a complex mechanism termed reverse cholesterol
transport (RCT)1 for removal (efflux) of excess cellular
cholesterol from peripheral cells and transport via serum
lipoproteins to liver hepatocytes, followed by uptake, oxidation to bile acids, and excretion into bile (reviewed in refs
1-4). Cholesterol efflux from peripheral cells involves three
distinct classes of proteins:
†
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1
Abbreviations: Caveolae/rafts, non-detergent affinity-purified lipid
rafts; non-rafts, non-detergent affinity-purified non-rafts; DRM, detergentresistant membranes; DSM, detergent-soluble membranes; ConA,
concanavalin A; SCP-2, sterol carrier protein-2; DHE, dehydroergosterol; HDL, high-density lipoprotein; LDL, low-density lipoprotein;
Apo A1, apolipoprotein A1; VLDL, very low density lipoprotein; BHT,
butylated hydroxytoluene; BLT-1, 2-hexyl-1-cyclopentanone thiosemicarbazone; PBS, phosphate-buffered saline; RTC, reverse cholesterol
transport.

First, intracellular cholesterol must be transported from
intracellular sites to the plasma membrane. This involves both
protein-mediated and vesicular processes (reviewed in refs
3 and 4). In protein-mediated molecular cholesterol transfer,
cholesterol synthesized in endoplasmic reticulum translocates
to the plasma membrane as a complex with one of two
proteins in the cytosol: (i) sterol carrier protein-2 (SCP-2),
which directly interacts with caveolin-1 localized in the
cytofacial leaflet of the plasma membrane (5, 6); or (ii)
caveolin-1/chaperones (reviewed in refs 3, 4, 6, and 7). In
the vesicular pathway, cholesterol traffics to the plasma
membrane from Golgi as caveolar vesicles, a process
inhibited by SCP-2 overexpression (reviewed in ref 3, 4, and
6). SCP-2’s inhibition of vesicular trafficking is consistent
with its high affinity for long-chain fatty acyl CoAs (8) and
phosphatidylinositol (9), both of which regulate vesicular
fusion and budding from the Golgi (reviewed in refs 1012). The protein-mediated molecular cholesterol transport and
vesicular transport differ in that the former is not energy
driven.
Second, cholesterol arriving at the plasma membrane is
translocated across the plasma membrane for efflux to
lipoproteins by processes that are as yet not clearly resolved.
The transbilayer distribution of cholesterol in the plasma
membrane from peripheral cells favors enrichment in the
cytofacial leaflet as indicated by selective quenching of
fluorescent sterols (13-17) and photo-cross-linking (18).
Although spontaneous transbilayer migration of cholesterol
in model membranes is relatively slow (reviewed in ref 19),
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that in plasma membranes is fast (seconds to minutes) (16,
17, 19). Several candidate proteins have been postulated to
facilitate cholesterol transbilayer migration from the cytofacial to the exofacial leaflet for subsequent efflux: (i)
Caveolin-1 is localized at the cytofacial leaflet of the plasma
membrane, directly binds cholesterol in Vitro (20, 21), and
is cross-linked by photoactivatable sterol in membranes (22,
23). However, there is as yet no direct evidence that this
interaction is energy-driven and/or directly facilitates cholesterol translocation/flipping across the plasma membrane
for efflux (reviewed in refs 1, 3, and 4). (ii) Although there
is no evidence demonstrating direct binding of cholesterol
by P-glycoprotein (P-gp, also known as MDR, multidrug
resistance protein), P-gp has been reported to enhance
cholesterol transbilayer migration to the exofacial leaflet for
efflux (reviewed in refs 24 and 25). Other reports indicate
that P-gp also enhances cholesterol desorption from the
plasma membrane for transport to the endoplasmic reticulum
and esterification (reviewed in ref 26) and that P-gp-mediated
lipid translocation is energy driven (reviewed in refs 2 and
27). Thus, P-gp may mediate bidirectional energy-driven
cholesterol transport at the plasma membrane. (iii) ABCA1,
an energy-driven ATP-binding cassette transporter, has also
been suggested to elicit unidirectional cholesterol transport
to the exofacial leaflet of the plasma membrane of extrahepatic tissues (reviewed in refs 2, 27, and 28). However,
photo-cross-linking studies indicate that ABCA1 does not
directly interact with cholesterol (29), and it has been
suggested that ABCA1 acts indirectly through enhancing
phospholipid desorption, which in turn facilitates transbilayer
cholesterol transport/desorption (reviewed in refs 2 and 28).
Taken together, these data indicate that transbilayer cholesterol transport mediated by P-gp and ABCA1 is energydriven (reviewed in refs 2 and 27).
Third, two distinct lipoprotein pathways serve as acceptors
of cholesterol desorbed from the cell surface. First, apolipoprotein A1 (apoA1) serves as the acceptor of ABCA1mediated phosphatidylcholine efflux, which facilitates cholesterol desorption to form precursor HDL in serum (reviewed
in refs 2 and 28). Second, serum HDL tethered to scavenger
receptor class B1 (SR-B1) facilitates bidirectional cholesterol
transfer from the plasma membrane (2, 30).
Whereas the organizing principle of low-density lipoprotein (LDL)-mediated cholesterol uptake through clathrincoated pits is now well understood, a similar concept for
HDL-mediated cholesterol efflux is only recently emerging.
There is extensive biochemical evidence from cell fractionation studies suggesting the presence of cholesterol-rich
domains (“lipid rafts”) in plasma membranes, yet only
recently has the existence of sterol-rich domains been
demonstrated in plasma membranes of living cells (reviewed
in ref 3). Real-time multiphoton imaging of dehydroergosterol (DHE), a naturally occurring fluorescent sterol,
demonstrated for the first time that in plasma membranes of
living cells sterol is not randomly distributed but instead is
localized in sterol-rich and -poor regions of the plasma
membrane (3, 31-33). Thus, it would appear that cholesterolrich rafts do exist in living cells and are not just an artifact
induced by subcellular fractionation protocols or nonphysiological probe molecules. Most important, biochemical
fractionation studies of cells and tissues to isolate these sterolrich/lipid rafts show that proteins involved in RCT are
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localized in lipid rafts/caveolae, i.e., SR-B1 and caveolin-1
(reviewed in refs 1-4, 30, 34, and 35). ABCA1 (36-40)
and P-gp (25, 41-48) are also found in lipid rafts/caveolae
or possibly in domains intermediate between lipid rafts/
caveolae and non-rafts. The above findings suggest that
cholesterol-rich lipid rafts/caveolae may provide a nexus for
mediating transfer of cholesterol between the plasma membrane and ABCA1-bound apoA1 or SR-B1-bound HDL.
However, to date there have been no biochemical studies
examining sterol dynamics between serum lipoproteins
(apoA1, HDL, LDL, VLDL) and purified lipid rafts/caveolae
versus non-rafts. To address this question, lipid rafts/
caveolae, caveolae, and non-rafts were isolated from peripheral cell types (fibroblasts, MDCK cells) according to two
classic methods: First, detergent-resistant membranes (DRM)
and detergent-soluble membranes (DSM) were isolated to
allow comparison of the results with the earlier biochemical
characterizations of lipid rafts/caveolae. Second, caveolaeenriched rafts and non-rafts were isolated by an affinity
chromatography method not utilizing detergents or high-pH
carbonate buffer (34, 49-52). These fractions were used to
determine if (i) caveolae-enriched domains were better
donors of cholesterol to lipoproteins (HDL, VLDL, LDL,
apoA1) than non-rafts and (ii) sterol dynamics between
lipoproteins (HDL, VLDL, LDL, apoA1) and caveolaeenriched domains or non-rafts was directional, i.e., reflecting
that observed with intact cells.
EXPERIMENTAL PROCEDURES
Materials. High-density lipoprotein (HDL), low-density
lipoprotein (LDL), apolipoprotein A1 (apoA1), and very lowdensity lipoprotein (VLDL) were purchased from EMD
Biosciences (San Diego, CA). BLT-1 was purchased from
Chem Bridge (San Diego, CA). Probucol was purchased from
VWR International (West Chester, PA). The following
antibodies were purchased from the indicated commercial
sources: rabbit polyclonal anti-sera to caveolin-1 and flotillin-1 (BD Transduction Laboratories, Palo Alto, CA); SRB1 and ABCA1 (Novus Biologicals, Littleton, CO); cholera
toxin B (Sigma, St. Louis, MO); P-gp (Santa Cruz Biotech,
Inc., Santa Cruz, CA); calnexin (Stressgen Biotech, Victoria,
BC, Canada); tubulin (Upstate, Lake Placid, NY); mouse
monoclonal antibodies to Na+,K+-ATPase (Affinity BioReagents, Inc., Golden, CO); protein disulfide isomerase
(PDI) (MBL International Corp., Woburn, MA); clathrin
(heavy chain, BD Transduction Laboratories). Cholesterol
(99+% pure) and egg PC (99+% pure) were purchased from
Steraloids (Wilmington, NH). EDTA, tris-base, sucrose,
phosphate-buffered saline (PBS), PMS-F, cholera toxin B,
and Percoll were obtained from Sigma Chemical (St. Louis,
MO). All solutions in which water was used contained MilliQ/deionized water.
Dehydroergosterol Synthesis. Dehydroergosterol (DHE)
occurs naturally in yeast and Red Sea sponge. However, DHE
utilized herein was chemically synthesized from ergosterol
(99+% pure) by use of a method developed in our laboratory
(31, 53). This method yielded DHE with a high degree of
purity (99+%), as ascertained by high-performance liquid
chromatography (34, 49).
Cell Culture. Murine L-cells were grown to confluency
at 37 °C and 5% CO2 in Higuchi medium (54), supplemented
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with fetal bovine serum (10%, Hyclone, Logan, UT), as
described earlier (34). Madin Darby Canine Kidney (MDCK;
American Type Culture Collection) cells were grown as
described earlier (52) in high-glucose (4.5 g/L) Dulbecco’s
Modification of Eagle’s medium (D-MEM) (Cellgrow/
Mediatech, Herndon, VA) supplemented with L-glutamine
(2 mM), sodium pyruvate (1 mM), nonessential amino acids
(0.1 mM), sodium bicarbonate (43.9 mM), fetal bovine serum
(5%), Serum Supreme (5%), penicillin (100 units/L), streptomycin (100 µg/L), and Fungizone (µg/L). Cells stocks,
maintained in 175 cm2 flasks (Sarstedt, Newton, NC), were
expanded into 500 cm2 trays (Corning, NY) and grown to
85% confluency for membrane isolations.
Isolation of Plasma Membrane Microdomains. Plasma
membranes were isolated from L-cell fibroblasts and resolved
into lipid raft/caveolae- and non-raft-enriched fractions by
a detergent-free, high-pH carbonate buffer-free, concanavalin-1 (ConA) affinity chromatography method as described
earlier (34). Detergent-resistant membranes (DRM) and
detergent-soluble membranes (DSM) were isolated from
MDCK cells as described previously (52). Plasma membranes (PM) from MDCK cells, isolated without the use of
detergents, were resolved into caveolae- and non-raftenriched membrane fractions according to a modified concanavalin A affinity chromatography method exactly as
described in ref 52.
Western Blot Analysis of Lipid Rafts/CaVeolae and NonRaft Fractions. To determine the relative purity of the lipid
rafts/caveolae-, caveolae-, and non-raft-enriched fractions
eluted from the ConA affinity columns, aliquots of each
fraction derived from L-cell fibroblasts or MDCK cells were
separated by SDS-PAGE and analyzed by Western blotting
to detect relative expression levels of caveolin-1, SR-B1,
ABCA1, P-gp, flotillin, clathrin, Na+,K+-ATPase, calnexin,
and PDI. Briefly, aliquots of each fraction were separated
by SDS-PAGE and analyzed as follows: Samples (10 µg)
were run on tricine gels (12%) and transferred to nitrocellulose membranes. The blots were blocked in 3% gelatin in
TBST (10 mM Tris-HCl, pH 8, 100 mM NaCl, 0.05%
Tween-20) for 1 h at room temperature and then washed
two times with TBST. The blots were incubated overnight
at room temperature with the respective primary antibodies
in 1% gelatin in TBST. After several washes with TBST,
the blots were incubated for 2 h at room temperature with
the appropriate secondary antibody (alkaline phosphatase
conjugates) in 1% gelatin TBST. The blot was washed three
times with TBST, and bands of interest were visualized by
development with Sigma Fast 5-bromo-4-chloro-3-indolyl
phosphate/nitro blue tetrazolium tablets according to the
manufacturer’s protocol. Images of each blot were acquired
using a single-chip charge-coupled device (CCD) video
camera and a computer workstation (IS-500 system from
Alpha Innotech, San Leandro, CA). Densitometric analysis
of image files was then performed (mean 8-bit gray scale
density) using Scion Image (Scion Corp., Frederick, MD)
to obtain relative levels of respective protein detected in each
fraction expressed as integrated density values. The fold
increase was calculated on the basis of expression levels in
the homogenate fraction.
Lipid Extraction and Analysis. Lipids from L-cell lipid
rafts/caveolae and non-raft fractions were extracted, resolved
into individual classes (cholesterol, phospholipid, cholesteryl
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ester, triacylglycerol, fatty acid), and quantitated as described
earlier (34). Ganglioside GM1 levels were determined by a
dot-blot technique as described elsewhere (34). Protein
concentration was determined according to the method of
Bradford from the dried protein extract residue digested
overnight in 0.2 M KOH (55). Amounts of individual lipid
classes were expressed as nanomoles of lipid per milligram
of protein. All glassware used for lipid analyses was washed
with sulfuric acid-chromate before use.
Labeling of Lipid Rafts/CaVeolae, CaVeolae, Non-Rafts,
and Lipoproteins with DHE. DHE-labeled donor and unlabeled acceptor membrane fractions were prepared from
MDCK or L-cell fibroblasts exactly as described in refs 13
and 52. DHE-labeled donor lipoproteins (VLDL, LDL, HDL,
apoA1) were prepared as described by Yeagle et al. (56)
and later modified by Smutzer (57). With regard to the latter,
the DHE, cholesterol, and egg PC at a molar ratio of 1:2:5
were mixed in chloroform. The solution was dried under N2
and subsequently under vacuum, at room temperature, to
remove any residual solvent. Next, a buffer containing 150
mM NaCl, 10 nM histidine, and 1 mM EDTA at pH 7.4
was added to a final concentration of 5 mg of phospholipid/
mL, and multilammelar liposomes were formed by vortexing
at room temperature. The liposomes were then incubated with
the lipoproteins at a ratio of 24 mg of lipoprotein to 5 mg of
liposome lipid (per milliliter of solution) and incubated in
the dark for 1 h at room temperature under N2 and gentle
stirring. The samples were then centrifuged for 20 min at
40 000 rpm in an SW41Ti rotor in a Beckman XL90
Ultracentrifuge (Beckman Instruments, Fullerton, CA) to
remove multilamellar vesicles as described (57).
Measurement of DHE Steady-State Fluorescence Polarization. All measurements of steady-state fluorescence
polarization were made with a PC1 spectrofluorometer with
photon-counting electronics (ISS Instruments, Inc., Champaign, IL) exactly as described earlier (49). Small amounts
of residual light scatter contributing to polarization measurements were corrected by converting polarization to anisotropy
according to the relationship r ) 2P/(3 - P) and subtracting
the residual fluorescence anisotropy from all experimental
data. To avoid potential inner filter artifacts, absorbance of
sample solutions at the excitation wavelengths were kept
below 0.15. Polarization/anisotropy measurements comprise
both static (limiting anisotropy) and dynamic (rotational rate)
parameters. Earlier studies showed that agents which fluidize
membranes (ethanol, anesthetics) primarily alter the static
(i.e., limiting anisotropy), but not dynamic (rotational),
components of polarization/anisotropy measurements (5863). Since limiting anisotropy represents a measure of the
cone angle of fluorescence probe rotation in lipid bilayers,
limiting anisotropy and, consequently, polarization of DHE
measured at very low, non-self-quenching DHE concentrations represent a useful relative measure of sterol mobility
in the purified membrane domain or lipoprotein.
Measurement of Sterol Exchange: DHE Release from SelfQuenching Fluorescence Polarization Assay. Sterol exchange
between the isolated membrane fractions and lipoproteins
was determined by using a fluorescent sterol (DHE) exchange
assay previously developed by our laboratory (34, 49, 52,
64). DHE was used as a probe for cholesterol dynamics
because it (i) is a natural product, (ii) is fluorescent, (iii)
closely resembles cholesterol in structure, (iv) has exchange
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kinetics very similar to those of cholesterol in model
membranes and biological membranes, (v) is taken up by
cultured cells such that >80% of endogenous sterol is
replaced by DHE without altering membrane lipid composition or sterol-sensitive enzymes, (vi) co-distributes with
cholesterol in model and biological membranes, (vii) does
not alter the activity of sterol-sensitive membrane proteins,
(viii) is nontoxic to cultured cells or animals, and (ix) is
readily incorporated into lipoproteins in ViVo and in Vitro
(reviewed in refs 13, 19, 31, and 64-73). The molecular
basis for the fluorescent sterol (DHE) exchange assay,
described in detail in an earlier publication (64), was recently
reviewed (74). Briefly, the underlying basis of the DHE
exchange assay is that fluorescence self-quenching of DHE
occurs in the donor membrane or lipoprotein, which contain
high levels of DHE, thereby resulting in low DHE fluorescence polarization values. Upon addition of a 10-fold excess
(by sterol) of acceptor membrane or lipoprotein, the donor
exchanges DHE one-for-one with cholesterol in the acceptor,
thereby resulting in release from self-quenching of DHE and
increased DHE polarization. To obtain baseline DHE fluorescence polarization of the donor (1.5 µg of protein/mL in
2 mL of 10 mM PIPES buffer), polarization was measured
for 20 min to ensure a stable signal baseline and to obtain
an initial value of DHE polarization. This was followed by
addition of a 10-fold excess of acceptor without DHE (15
µg/mL in the 2 mL sample). The DHE polarization was
subsequently recorded during 20 s intervals for 3-4 h to
monitor sterol transfer between membranes and lipoproteins.
Inhibitors of ABCA1- and SR-B1-Mediated Sterol Dynamics between ApoA1 and MDCK CaVeolae. To resolve the
relative contributions of ABCA1 and SR-B1 to sterol
dynamics between caveolae and apoA1, DHE exchanges
between MDCK caveolae donors and apoA1 acceptor were
repeated in the presence of BLT-1 to inhibit SR-B1-mediated
sterol efflux (75), Probucol to inhibit ABCA1-mediated sterol
efflux (75), and anti-ABCA1 to inhibit ABCA1-mediated
sterol efflux with anti-tubulin as a control. In brief, before
each exchange stock solutions of 10 mM Probucol or BLT-1
were made in DMSO. Prior to initiating exchange, the
MDCK donor caveolae were incubated with Probucol (20
µM), BLT-1 (10 µM), anti-ABCA1 (20 µM), or anti-tubulin
(20 µM) in the dark for 30 min as described earlier (75). A
baseline polarization of the donor with these treatments was
recorded for 30 min, followed by addition of the acceptor
apoA1. Data were recorded for 4 h. For each treatment, a
total of n ) 2-3 runs was used for calculations.
Standard CurVes for the Sterol Exchange Assay. Standard
curves for sterol exchange were prepared basically as
described earlier by our laboratory (34, 49, 52, 64). The
standard curve that calculates the fraction of DHE remaining
in the donor during an exchange is a polynomial equation
involving polarization P of the exchange in the form of

P ) Σ bnXdn

(1)

where Xd is the mole fraction of DHE left in the donor. For
sterol exchange between donor and acceptor, a polynomial
with two terms yielded a fit with r2 ) 0.9999, that is, eq 2

P(x) ) b0 + b1Xd + b2Xd2
where b0 ) 0.3261, b1 ) 0.016, and b2 ) -0.144.

(2)

Calculation of the Initial Rate of Sterol Transfer. The
initial rate of DHE exchange between donor and acceptor
was estimated from the first 10 min of exchange data by
using the standard curve described above in eq 2 (76). In
essence, eq 2 is the definitive relationship that describes the
exchange between donor and acceptor. Taking the time
derivative of eq 2 yields

(dP/dt) ) b1(dXd/dt) + 2b2Xd(dXd/dt)

(3)

As t f 0, Xd f 1 (i.e., initial rate criteria), and by rearranging
eq 3, the following expression is obtained:

[1/(b1 + 2b2)](dP/dt)tf0 ) (dXd/dt)tf0

(4)

To obtain the molar transfer rate of DHE (d[DHE]/dt) from
donor to acceptor, dXd/dt was transformed into d[DHE]/dt
by factoring in the initial donor protein concentration (1.5
µg of protein/mL), the total sterol/protein concentration in
the donor (1011.02 pmol of total sterol/µg of protein), and
the values of b1 (0.016) and b2 (-0.144). Combining this
information with eq 4 yielded eq 5:

(d[DHE]/dt)tf0 ) -2253 pmol × (dP/dt)tf0

(5)

The initial rate of DHE transfer was directly estimated by
substituting the initial measured rate of fluorescence polarization change per unit time (i.e., minutes) for (dP/dt)tf0.
Calculation of the Kinetic Parameters of Sterol Exchange.
The kinetic parameters of exchange between donor/acceptor
pairs were determined by use of the standard curve equation,
i.e., eq 2, and the equation for a one-exponential exchange

X ) f1 exp(-kt) + f2

(6)

where f1 and f2 are the exchangeable and nonexchangeable
fractions, respectively, of the sterol in the exchange assay
and k is the rate constant of the exchange. The expression
for X in eq 6 was substituted into eq 2 to obtain the
expression describing the exchange:

P(x) ) b0 + b1[f1 exp(-kt) + f2] +
b2[f1 exp(-kt) + f2]2 (7)
The exchange curves were fit to eq 8 with r2 values varying
from 0.97 to 0.99. The halftime, t1/2, of the exchanges was
defined by the following equation:

t1/2 ) (ln 2)/k

(8)

Data and Statistical Analyses. All curve-fitting and data
analyses herein were performed by use of SigmaPlot (Jandel
Scientific, San Rafael, CA) scientific data analysis and
graphing software.
RESULTS
Lipid Raft/CaVeolae, CaVeolae, and Non-Raft Distribution
of Proteins and Lipids Transported by Lipoproteins Interacting with the RCT Pathway. As indicated under Experimental
Procedures, lipid raft/caveolae- and non-raft-enriched fractions were simultaneously isolated by ConA affinity chromatography of purified plasma membranes from L-cell
fibroblasts (34), whereas caveolae- and non-raft-enriched
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Table 1: Lipid Distribution in L-Cell Lipid Rafts/Caveolae and
Non-Raftsa
lipid

non-rafts
(nmol/mg of protein)

lipid rafts/caveolae
(nmol/mg of protein)

cholesterol
cholesteryl ester
triacylglycerol
phospholipid
total lipid

345 ( 86
43 ( 13
23 ( 6
266 ( 24
904 ( 104

1016 ( 75*
13 ( 3*
48 ( 5*
1681 ( 152*
3117 ( 152*

a Lipids were extracted, resolved into individual classes by thin layer
chromatography, and quantitated as described under Experimental
Procedures. Total lipid represents the sum of cholesterol, cholesteryl
ester, triacylglycerol, phospholipid, and small amounts of other lipids
(e.g., fatty acids, sphingolipids, etc.) not shown. Values represent the
mean ( SD (n ) 3-7). * indicates P < 0.05 vs non-rafts.

FIGURE 1: Quantitative analysis of specific lipid raft and non-raft
markers in membranes isolated from L-cell fibroblasts and MDCK
cells. Caveolae protein markers [caveolin-1 (cav-1), SR-B1,
ABCA1, and P-gp] in membranes isolated from L cells (panel A)
and MDCK cells (panel B) were quantified as described under
Experimental Procedures. Fold increases of caveolae lipid marker
GM1 (panel C), non-caveolar raft protein marker flotillin-1 (panel
D), non-raft PM markers clathrin and Na+,K+-ATPase (panel E),
and intracellular markers calnexin and PDI (panel F) were
determined for MDCK-derived membranes. Open bar indicates
plasma membrane (PM); solid bar indicates caveolae-enriched
fractions. Western blots are shown as insets. Values represent the
mean ( SE (n ) 3-7). / indicates P < 0.05 fold increase vs
homogenate; # indicates P < 0.05 fold decrease vs homogenate;
@ indicates P < 0.05 fold increase vs PM.

plasma membrane fractions were isolated by concanavalin
A affinity chromatography modified as described in ref 52.
To confirm the purity of the ConA adherent and non-adherent
fractions, Western blot and lipid analyses were performed
to determine the presence of select protein and lipid
markers.
The ConA adherent fraction isolated from L-cell plasma
membranes was enriched in the caveolae markers caveolin-1
(Figure 1A) and SR-B1 (Figure 1A), the lipid raft marker
flotillin (not shown), and other proteins detected in lipid rafts/
caveolae including ABCA1 and to a lesser extent P-gp
(Figure 1A). Concomitantly, the ConA adherent fraction was
deficient in the non-raft marker to Na+,K+-ATPase, which
was enriched in the ConA non-adherent fraction (not shown).
These data confirmed earlier findings indicating that the
ConA adherent fraction isolated from L-cells was enriched
in lipid rafts/caveolae (34). To further confirm that the ConA
non-adherent and adherent fractions from L-cell plasma
membranes represented non-raft- and lipid raft-enriched
fractions, lipid analyses for marker lipids was performed as
described under Experimental Procedures. Lipid rafts from

peripheral cells are known to be enriched in total lipids,
cholesterol, and phospholipids (reviewed in ref 52). Lipid
extraction and analysis revealed that the lipid raft/caveolae
fraction was enriched in total lipid, cholesterol, and phospholipid as compared to non-raftss3.5-, 3-, and 6.3-fold,
respectively (Table 1). In addition, the lipid rafts/caveolae
contained small amounts of cholesteryl ester and triacylglycerol (Table 1). Triacylglycerol was enriched 2.1-fold in
lipid rafts/caveolae as compared to non-rafts, whereas the
opposite was observed for cholesteryl ester (Table 1).
Cholesteryl ester and triacylglycerol represented only 0.4 and
1.5% of total lipid, respectively, in lipid rafts/caveolae, but
significantly more (4.7 and 2.5% of total lipid, respectively)
in non-rafts (Table 1). Although cholesteryl ester and
triacylglycerol are known to be taken up through lipid rafts/
caveolae from SR-B1-bound lipoproteins, neither apoB nor
apoA1 was detected in the lipid rafts/caveolae or non-raft
fractions (not shown), indicating that the presence of small
amounts of cholesteryl ester and triacylglycerol in lipid rafts/
caveolae or non-rafts was not due to contaminant adherent
lipoproteins. Thus, lipid rafts/caveolae were lipid rich,
cholesterol-rich, and phospholipid-rich and contained small
amounts of lipids (cholesteryl ester, triacylglycerol).
The ConA adherent fraction isolated by the detergent-free
method from MDCK cell plasma membranes was also rich
in a caveolae protein marker [SR-B1 (Figure 1B)] and other
proteins such as ABCA1 (Figure 1B) and less so P-gp (Figure
1B)sconfirming earlier findings (52). The 3-fold enrichment
of GM1 (Figure 1C), a caveolae lipid marker, between the
PM and caveolae fraction closely resembles the approximately 4-fold PM to caveolae enrichment observed with
detergent-free cryoEM methodologies (77). However, the
ConA adherent fraction isolated from MDCK cells was
essentially deficient in the lipid raft marker protein flotillin-1
(Figure 1D). Flotillin-1 is a known lipid raft, non-caveolar
marker (78). In contrast, the non-raft protein markers clathrin
and Na+,K+-ATPase were absent from the ConA adherent
fraction (Figure 1E) but enriched in the non-adherent fraction
(not shown). The ConA adherent fraction was also devoid
of the intracellular markers calnexin and PDI (Figure 1F).
These data together with earlier findings (52) indicated that
the ConA adherent fraction isolated from MDCK cell plasma
membranes was highly enriched in caveolae, but not lipid
rafts.
Thus, on the basis of protein as well as lipid markers and
consistent with earlier findings (34, 52), in subsequent
sections the ConA adherent fraction isolated from L-cells
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FIGURE 2: Sterol exchange between L-cell and MDCK-derived plasma membrane (caveolae-enriched and non-raft) donors to lipoprotein
acceptors. DHE exchanges between L-cell lipid rafts/caveolae donors (panel A), L-cell non-raft donors (panel B), MDCK caveolae donors
(panel C), and MDCK non-raft donors (panel D) to lipoprotein acceptors were measured by monitoring DHE polarization as described
under Experimental Procedures: b, exchange to LDL; O, sterol exchange to HDL; 1, exchange to apoA1; 3, sterol exchange to VLDL.
All curves show sterol exchange after addition of 10-fold excess (by sterol) acceptor lipoprotein.

will be referred to as lipid rafts/caveolae, whereas that
isolated from MDCK cells will be referred to as caveolae.
Sterol Exchange between L-Cell Plasma Membrane Lipid
Raft/CaVeolae or Non-Raft Donors and Lipoprotein Acceptors. The molecular basis for the polarization sterol exchange
assays is release of DHE from self-quenching. In donor
membrane fractions (labeled with DHE) the DHE content is
high, resulting in self-quenching and low polarization. In
contrast, as the donor DHE is exchanged one-for-one with
cholesterol in the acceptor (present at 10-fold excess to
minimize back-transfer of DHE and not labeled with DHE)
the DHE is released from self-quenching, and polarization
increases as the exchange process proceeds. Examination of
representative sterol exchange curves indicated that in
membrane fractions isolated from L-cell fibroblasts sterol
transfer from lipid raft/caveolae donors to lipoprotein acceptors was relatively slow and dependent on the type of
lipoprotein acceptor (Figure 2A). These visually apparent
trends were confirmed by quantitative analysis of multiple
sterol exchange curves (Table 2). The initial rates of
molecular sterol exchange between caveolae/raft DHE donors
and lipoprotein acceptors differed nearly 9-fold, depending
on the lipoprotein, and were in the order LDL > VLDL >
HDL, apoA1 (Table 2). Multiexponential analysis of multiple
exchange curves revealed that they best fit two components: (i) a relatively rapidly exchangeable sterol pool with
half-times near 1-4 h comprised about 12-20% of total
sterol; (ii) a very slowly exchangeable sterol pool (half-time
of days) represented the majority (>80%) of sterol (Table
2). The half-times of molecular sterol transfer from the
rapidly exchangeable sterol pool in lipid rafts/caveolae donors

to lipoprotein acceptors were shortest in the order LDL >
VLDL > HDL, apoA1 (Table 2). However, the fraction of
sterol in both the rapidly exchangeable and very slowly
exchangeable sterol pool in the donor lipid rafts/caveolae
was independent of the lipoprotein acceptor.
In contrast, representative exchange curves indicated that
sterol exchange between non-raft donors and lipoprotein
acceptors appeared to be slower (Figure 2B) than that in the
reverse direction (Figure 2A). This was confirmed by
examination of initial rates of molecular sterol exchange
between non-raft donors and lipoprotein acceptors, which
were all very slow and similar for all lipoproteins except
for exchange with apoA1, which was the slowest of any
transfer examined (Table 2). Finally, non-rafts had significantly less or no rapidly exchangeable sterol pool (Table 2).
Thus, sterol exchange between lipid rafts/caveolae donors
and lipoprotein acceptors proceeded most rapidly to LDL
and VLDL. However, none of the lipoproteins examined
altered the proportion of rapidly and slowly/nonexchangeable
sterol pools in the donor lipid rafts/caveolae. In contrast, nonrafts were very poor sterol donors to lipoprotein acceptors
and exhibited a very large or exclusively very slowly
exchangeable sterol pool.
Sterol Exchange between MDCK Plasma Membrane
CaVeolae or Non-Raft Donors and Lipoprotein Acceptors.
Representative sterol exchange curves indicated that sterol
transfer from MDCK caveolae to lipoprotein acceptors was
rapid (Figure 2C). The initial rates of molecular sterol
exchange between MDCK caveolae donors and lipoprotein
acceptors were in the order VLDL > LDL > HDL, apoA1
(Table 2). Multiexponential analysis showed that the ex-

Sterol Dynamics between Lipoproteins and Caveolae

Biochemistry, Vol. 46, No. 48, 2007 13897

Table 2: Sterol Exchange between Lipid Rafts/Caveolae, Non-Raft Fractions, and Lipoprotein Acceptorsa
donor

acceptor

initial rate (pmol/min)

t1/2 (min)

f1

f2

0.171 ( 0.016
0.131 ( 0.013
0.124 ( 0.024
0.192 ( 0.022

0.829 ( 0.046
0.869 ( 0.023
0.876 ( 0.029
0.808 ( 0.035

lipid rafts/caveolae

LDL
HDL
ApoA1
VLDL

L-Cell Fibroblasts
0.693( 0.034
41 ( 6
0.107( 0.021+
205 ( 28+
0.080( 0.015+
260 ( 21+
0.232( 0.040+
138 ( 18+

non-rafts

LDL
HDL
ApoA1
VLDL

0.129( 0.026*
0.062( 0.018
0.036( 0.009*
0.066( 0.028*

144 ( 20*
-*
-*
178 ( 27

0.112 ( 0.021*
-*
0.069 ( 0.019*

0.888 ( 0.031
1.000*
1.000*
0.931 ( 0.027*

caveolae

LDL
HDL
ApoA1
VLDL

MDCK Cells
0.389 ( 0.037
52 ( 9
0.139 ( 0.015+
109 ( 21+
0.103 ( 0.018+
131 ( 15+
0.528 ( 0.022+
140 ( 31+

0.127 ( 0.011
0.096 ( 0.028
0.079 ( 0.017+
0.221 ( 0.017+

0.873 ( 0.039
0.904 ( 0.035
0.921 ( 0.021
0.779 ( 0.024

non-rafts

LDL
HDL
ApoA1
VLDL

0.031 ( 0.009*
0.039 ( 0.006*
0.036 ( 0.007*
0.029 ( 0.009*

-*
-*
-*
-*

1.000*
1.000*
1.000*
1.000*

-*
-*
-*
-*

a
DHE was incorporated at low, non-self-quenching levels into the isolated L-cell lipid rafts/caveolae and MDCK caveolae domains as described
under Experimental Procedures. Polarization values represent the mean ( SD (n ) 7). * indicates P < 0.05 vs caveolae-enriched domains; +
indicates P < 0.05 vs LDL.

change curves again best fit to two components: a relatively
rapidly exchangeable sterol pool with half-times near 1-2
h comprised about 10-20% of total sterol, and a very slowly
exchangeable sterol pool (half-time of days) represented the
majority (>80%) of sterol (Table 2). The half-times of
molecular sterol transfer from the rapidly exchangeable sterol
pool in caveolae to lipoproteins were shortest in the order
LDL > VLDL, HDL, apoA1 (Table 2). Again, the fraction
of rapidly exchangeable and very slowly exchangeable sterol
pool in the donor caveolae was largely independent of the
lipoprotein acceptor, although small differences were seen
with apoA1 and VLDL (Table 2).
In contrast, sterol exchange between MDCK non-raft
donors and lipoprotein acceptors was extremely slow as
compared to exchange between caveolae donors and lipoprotein acceptors (Figure 2D). Initial rates of molecular sterol
exchange between MDCK non-raft donors and lipoprotein
acceptors were as much as 18-fold slower between non-raft
donors and lipoprotein acceptors than between caveolae
donors and lipoprotein acceptors (Table 2). Furthermore,
there were no significant differences in initial rates of sterol
exchange from non-raft donors to lipoprotein acceptors
regardless of lipoprotein type (Table 2). Finally, MDCK nonrafts had no rapidly exchangeable sterol pool, regardless of
the type of lipoprotein acceptor (Table 2). Thus, sterol
transfer from MDCK non-raft donors to lipoprotein acceptors
was slower than that from caveolae, unresponsive to lipoproteins, and exhibited only a very slowly exchangeable
sterol pool.
Sterol Exchange between MDCK DRM or DSM Donors
and Lipoprotein Acceptors. To determine if MDCK sterol
exchange dynamics between caveolae (purified by affinitychromatography without the use of detergents) and lipoprotein acceptors was also reflected by caveolae isolated with
the use of detergents, DRM and DSM were isolated as
described under Experimental Procedures. Representative
sterol exchange curves between MDCK DRM donors and
lipoprotein acceptors indicated that exchange to LDL and
VLDL was more rapid than that to HDL or apoA1 acceptors

(Figure 3A). This was confirmed by comparison quantitative
analysis of multiple exchanges which indicated that the initial
rates of sterol transfer from DRM donors to lipoprotein
acceptors were in the relative order VLDL > LDL, HDL,
apoA1 (Table 3). Multiexponential analysis of exchange
curves from DRM donors to lipoprotein acceptors best fit
to two components: a relatively rapidly exchangeable sterol
pool with half-times near 1-2 h comprised about 10-20%
of total sterol, and a very slowly exchangeable component
(half-time of days) represented the majority (>80%) of sterol
(Table 3). The half-times of molecular sterol exchange
between the rapidly exchangeable sterol pool in DRM donors
to lipoprotein acceptors were shortest in the order VLDL >
LDL, HDL, apoA1 (Table 3). The fraction of rapidly
exchangeable and very slowly exchangeable sterol pool in
the donor DRM was largely independent of the lipoprotein
acceptor, although small differences were seen between
apoA1 and VLDL (Table 3). In contrast, sterol exchange
between MDCK DSM donors and lipoprotein acceptors was
6-20 times slower than that from DRM, unresponsive to
the type of lipoprotein acceptor, and exhibited no rapidly
exchangeable sterol pool (Table 3). Thus, the kinetics and
relative order of initial rates of molecular sterol exchange
between DRM donors and lipoprotein acceptors also indicated that VLDL and LDL were the best sterol acceptors.
Thus, DSM were poor sterol donors to any of the lipoproteins
examined and exhibited only a single very slowly exchangeable sterol pool.
Sterol Exchange between Lipoprotein Donors and L-Cell
Plasma Membrane Lipid Rafts/CaVeolae or Non-Raft Acceptors. Since the above studies indicated that LDL and
VLDL were better sterol acceptors from lipid rafts/caveolae
and DRM, it was important to determine if this was also the
case in the reverse direction, i.e., if LDL and VLDL were
good sterol donors to lipid rafts/caveolae acceptors. Therefore, DHE was incorporated into the different lipoproteins
(HDL, LDL, VLDL, apoA1) by using a method initially
prescribed by Yeagle et al. (56) and later modified by
Smutzer (57). To characterize the spectral parameters of DHE
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FIGURE 3: MDCK and L-cell membrane donor/acceptor sterol exchanges to lipoproteins. DHE exchanges between MDCK detergentresistant membrane (DRM) donors and lipoprotein acceptors (panel A), lipoprotein donors and L cell lipid rafts/caveolae acceptors (panel
B), lipoprotein donors and L cell non-raft acceptors (panel C), and lipoprotein donors and MDCK caveolae acceptors were measured by
monitoring DHE polarization as described under Experimental Procedures: b, exchange to LDL; O, sterol exchange to HDL; 1, exchange
to apoA1; 3, sterol exchange to VLDL.
Table 3: Sterol Exchange between MDCK Donors (DRM, DSM) and Lipoprotein Acceptorsa
donor

acceptor

initial rate
(pmol/min)

t1/2 (min)

f1

f2

DRM

LDL
HDL
ApoA1
VLDL

0.185 ( 0.023
0.115 ( 0.019+
0.101 ( 0.024+
0.699 (0.018+

127 ( 32
145 ( 28
169 ( 18
46 ( 14+

0.143 ( 0.041
0.106 ( 0.019
0.092 ( 0.016
0.198 ( 0.038

0.857 ( 0.032
0.894 ( 0.028
0.908 ( 0.027
0.802 ( 0.036

DSM

LDL
HDL
ApoA1
VLDL

0.034 ( 0.013*
0.036 ( 0.012*
0.041 ( 0.009*
0.033 ( 0.010*

-*
-*
-*
-*

1.000*
1.000*
1.000*
1.000*

-*
-*
-*
-*

a
DHE was incorporated at low, non-self-quenching levels into the isolated detergent resistant membranes (DRM) and detergent soluble membranes
(DSM) as described under Experimental Procedures. Values represent the mean ( SD (n ) 7). * indicates P < 0.05 vs DRMs; + indicates P < 0.05
vs LDL.

in HDL, LDL VLDL, and apoA1, the polarization and
fluorescence emission maxima were determined for each
lipoprotein-DHE complex (Table 4). DHE polarization
values did not significantly differ between lipoproteins,
ranging from 0.1786 ( 0.0072 (apoA1-DHE) to 0.1904 (
0.0083 (VLDL-DHE). DHE emission maxima were also
similar in all DHE-lipoprotein complexes, which characteristically exhibited emission maxima at 357 ( 3, 374 ( 2,
and 388 ( 4 nm (Table 4). Comparison of these spectra and
emission maxima with those of crystalline DHE (31) showed
the absence of crystalline DHE in the lipoprotein-DHE
complexes. These spectral properties of DHE confirmed
those previously reported for DHE in VLDL, LDL, and HDL
(56, 57, 71, 72, 79, 80). Finally, since the purified lipoprotein
fractions (especially VLDL and LDL) lack the sequestering
activity of lecitihin:cholesterol acyltransferase, all of the DHE
incorporated into the lipoproteins was unesterified DHE,

Table 4: Spectral Parameters of DHE Incorporated into Different
Lipoproteinsa
emission maxima (nm)
lipoprotein

polarization

peak 1

peak 2

peak 3

HDL
ApoA1
LDL
VLDL

0.1833 ( 0.0099
0.1786 ( 0.0072
0.1892 ( 0.0078
0.1904 ( 0.0083

357
358
355
358

374
373
374
375

387
388
392
385

a Dehydroergosterol (DHE) was incorporated at low, non-selfquenching levels into HDL, ApoA1, LDL, and VLDL as described
under Experimental Procedures. The fluorescence polarization values
represent the mean ( SE (n ) 30). All values are (SE. Emission
maxima of the three peaks of DHE correspond with those observed
previously for membranes.

confirming earlier studies (72, 79, 80). Thus, all exchange
curves between lipoproteins and purified plasma membrane
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Table 5: Sterol Exchange between Lipoprotein Donors and Plasma Membrane Domain (Caveolae-Enriched, Non-Rafts) Acceptorsa
donor

acceptor

LDL
HDL
ApoA1
VLDL

lipid rafts/caveolae

LDL
HDL
ApoA1
VLDL

non-rafts

LDL
HDL
ApoA1
VLDL

lipid rafts/caveolae

LDL
HDL
ApoA1
VLDL

non-rafts

initial rate (pmol/min)

f1

f2

L-Cell Fibroblasts
0.083 ( 0.016
167 ( 21
0.269 ( 0.029+
113 ( 17
0.435 ( 0.031+
85 ( 16+
0.056 ( 0.011
-

t1/2 (min)

0.083 ( 0.006
0.188 ( 0.023+
0.229 ( 0.027+
-

0.917 ( 0.024
0.812 ( 0.026+
0.721 ( 0.034+
1.000

0.037 ( 0.009*
0.051 ( 0.018*
0.045 ( 0.026*
0.042 ( 0.019

-*
-*
-*
-

-*
-*
-*
-

1.000*
1.000*
1.000*
1.000*

MDCK Cells
0.112 ( 0.013
0.370 ( 0.032+
0.296 ( 0.024+
0.043 ( 0.010+

159 ( 18
109 ( 14
175 ( 29
-+

0.106 ( 0.009
0.243 ( 0.022+
0.129 ( 0.011
-+

0.894 ( 0.011
0.757 ( 0.034+
0.871 ( 0.043
-+

0.039 ( 0.010*
0.040 ( 0.012*
0.039 ( 0.019*
0.044 ( 0.015

-*
-*
-*
-*

-*
-*
-*
-*

1.000*
1.000*
1.000*
1.000*

a
DHE was incorporated at low, non-self-quenching levels into HDL, ApoA1, LDL, and VLDL as described under Experimental Procedurs.
Values represent the mean ( SD (n ) 7). * indicates P < 0.05 vs lipid rafts/caveolae; + indicates P < 0.05 vs LDL.

fractions represent exchange (not net transfer) of unesterified
sterol, in the absence of sequestering actions of esterification
enzymes.
Examination of representative sterol exchange curves
between lipoprotein donors and lipid rafts/caveolae isolated
from L-cell plasma membranes indicated that sterol exchange
was most marked from apoA1 (Figure 3B, 1) and HDL
(Figure 3B, O) donors. In contrast, exchange from LDL
(Figure 3B, b) and VLDL (Figure 3B, 3) donors to lipid
rafts/caveolae acceptors was very slow. These trends were
confirmed by quantitative analysis of initial rates from
multiple exchanges (Table 5). The initial rate of sterol
exchange between lipoprotein donors and L-cell lipid rafts/
caveolae acceptors was most rapid in the order apoA1 >
HDL > LDL, VLDL (Table 5). Furthermore, initial rates of
sterol exchange between apoA1 and HDL donors and L-cell
lipid rafts/caveolae acceptors (Table 5) were 5.4- and 2.5fold, respectively, faster than in the reverse direction (Table
3). In contrast, initial rates of sterol exchange between LDL
or VLDL donors and L-cell caveolae/lipid raft acceptors
(Table 5) were 8.3- and 4.1-fold, respectively, slower than
in the reverse direction (Table 3). Multiexponential analysis
of the sterol exchange curves from lipoprotein donors to
L-cell fibroblast lipid rafts/caveolae acceptors best fit to two
components for apoA1, HDL, and LDL donors, whereas that
from VLDL donors was too slow to resolve (Table 5). The
half-times of exchange of the most rapidly exchangeable
component from lipoprotein donors to the lipid rafts/caveolae
acceptors were in the order of the most rapid to the least
rapid: apoA1, HDL > LDL . VLDL (Table 5). Lipoprotein
donors with shortest half-times and fastest initial rates had
the largest rapidly exchangeable sterol fractionsapoA1 and
HDL (Table 5). In contrast, sterol exchange between the
respective lipoprotein donors and non-raft acceptors isolated
from L-cell plasma membranes was almost nondetectable
(Figure 3C). There were no statistically significant differences
in initial rates of sterol exchange between the various
lipoprotein donors and non-raft acceptors. Initial rates of
sterol exchange between apoA1, HDL, LDL, or VLDL
donors and non-raft acceptors were 9.7-, 5.3-, 2.2-, and 1.3-

fold, respectively, slower than to lipid rafts/caveolae acceptors (Table 5). In summary, as shown by fast initial rates
and small half-times of sterol exchange, apoA1 and HDL
were the best sterol donors to L-cell fibroblast lipid rafts/
caveolae acceptors. Furthermore, apoA1 and HDL donors
exhibited a larger exchangeable sterol fraction as compared
to LDL and VLDL. Non-rafts were poor sterol acceptors,
regardless of the type of lipoprotein donor, and all of the
lipoprotein donors exhibited only a single very slowly
exchangeable sterol pool.
Sterol Transfer from Lipoprotein Donors to MDCK
Plasma Membrane CaVeolae and Non-Raft Acceptors.
Representative sterol exchange curves between lipoprotein
donors and MDCK cell caveolae acceptors also appeared
most rapid for apoA1 (Figure 3D, 1) and HDL (Figure 3D,
O) donors. Initial rates of sterol exchange between lipoprotein
donors and caveolae acceptors were in the order HDL, apoA1
> LDL > VLDL (Table 5). Initial rates of sterol exchange
between apoA1 and HDL donors and MDCK caveolae
acceptors (Table 5) were 3.6- and 2.7-fold, respectively,
faster than in the reverse direction (Table 3). In contrast,
initial rates of sterol exchange between LDL or VLDL donors
and MDCK cell caveolae acceptors (Table 5) were 3.4- and
12.2-fold, respectively, slower than in the reverse direction
(Table 3).
Exchange curves between lipoprotein donors and MDCK
caveolae acceptors best fit to two components for the more
rapid exchanges (apoA1, HDL, LDL donors), but not from
VLDL donors, which was too slow to resolve (Table 5). The
HDL and less so apoA1 donors appeared to have the largest
rapidly exchangeable sterol fraction, whereas that of LDL
and VLDL was smaller or nonexistent (Table 5). Lipoprotein
donors exhibiting the shortest half-times and fastest initial
rates generally had the largest rapidly exchangeable sterol
fractionsapoA1 and HDL (Table 5). The half-times of
exchange of the rapidly exchangeable sterol pool between
the various lipoprotein donors and the MDCK caveolae
acceptors were in the approximate order from the fastest (i.e.,
shortest half-time) to the slowest HDL, apoA1, LDL .
VLDL (Table 5).

13900 Biochemistry, Vol. 46, No. 48, 2007

Storey et al.

FIGURE 4: Sterol transfer from MDCK caveolae donors to apolipoprotein A1 acceptor in the presence of different inhibitors. DHE exchange
between MDCK caveolae donors and apoA1 was measured by monitoring DHE polarization as described under Experimental Procedures.
The effect of several inhibitors including anti-ABCA1 (panel A), BLT-1 (panel C), Probucol (panel D), and a control for nonspecific
adsorption of antibodies (anti-tubulin, panel B) on sterol exchange was determined: b, MDCK caveolae donor only; O, sterol exchange to
the apoA1 without inhibitors present; 1, exchange to the respective inhibitors (anti-ABCA1, BLT-1, Probucol) or control (anti-tubulin). All
curves show sterol exchange from donor MDCK caveolae after addition of 10-fold excess (by sterol) acceptor apoA1.

In contrast, there were no differences in initial rates of
sterol exchange between the various lipoprotein donors and
MDCK cell non-raft acceptors. Furthermore, initial rates of
sterol exchange between apoA1, HDL, LDL, or VLDL
donors and MDCK non-raft acceptors were 7.6-, 9.3-, 2.9-,
and 1.0-fold, respectively, slower than to MDCK caveolae/
lipid rafts (Table 5). In summary, apoA1 and HDL were the
best sterol donors to MDCK cell caveolae acceptors.
Furthermore, apoA1 and HDL tended to exhibit a larger
rapidly exchangeable sterol fraction than LDL or VLDL.
MDCK cell non-rafts were poor sterol acceptors from
lipoproteins, regardless of the type of lipoprotein, and all of
the lipoprotein donors exhibited only a single very slowly
exchangeable sterol pool with non-raft acceptors.
RelatiVe Contributions of ABCA1 and SR-B1 to Sterol
Exchange between MDCK CaVeolae Donors and ApoA1
Acceptors: Effect of Inhibitors. Sterol exchange between
MDCK caveolae donors and apoA1 acceptor was examined
in the presence of several inhibitors [BLT-1 to inhibit SRB1 (75), Probucol to inhibit ABCA1 (75), and anti-ABCA1
to inhibit ABCA1] and one non-inhibitor (anti-tubulin) to
apoA1 sterol exchange. As shown by representative exchange
curves, anti-ABCA1 reduced sterol exchange between MDCK
caveolae donors and apoA1 (Figure 4A, 1) as compared to
control in the absence of anti-ABCA1 (Figure 4A, O) to
reduce the initial rate of sterol exchange by 27 ( 8% (n )
3). This inhibition was not due to nonspecific antibody
adsorption as treatment with anti-tubulin, a non-inhibitor of
apoA1, did not affect sterol exchange (Figure 4B) or initial
rate. These findings were confirmed with the ABCA1inhibiting drug Probucol, which inhibited sterol exchange
(Figure 4C, 1) as compared to control in the absence of
Probucol (Figure 4C, O) to reduce the initial rate of sterol
exchange by 35 ( 9% (n ) 3). Finally, the SR-B1 inhibitor
BLT-1 reduced sterol exchange (Figure 4C, 1) as compared
to control in the absence of BLT-1 (Figure 4C, O) to reduce
the initial rate of sterol exchange by 45 ( 16% (n ) 3). In

summary, inhibitors of ABCA1 (i.e., anti-ABCA1, Probucol)
and SR-B1 (BLT-1) were observed to decrease sterol
exchange between MDCK caveolae donors and apoA1.
Taken together, these data suggest that 72-80% of sterol
exchange between MDCK caveolae donors and apoA1 is
associated with ABCA1 and SR-B1 in nearly equal proportion. Furthermore, finding that a significant proportion (2028%) of cholesterol flux was not due to either ABCA1 or
SR-B1 was consistent with findings in other peripheral cell
types (75).
DISCUSSION
Although the organizing principle of LDL-mediated
cholesterol uptake (i.e., LDL receptor-mediated uptake
through clathrin coated pits) is now well understood, much
remains to be determined regarding the molecular details and
organizing principles for selective cholesterol uptake/efflux.
As indicated in the introduction, it is not yet completely clear
whether selective cholesterol uptake/efflux in peripheral cells
can be attributed to plasma membrane microdomains termed
lipid rafts/caveolae. Furthermore, two rather than one distinct
lipoprotein pathways serve selective cholesterol efflux/uptake
(also called reverse cholesterol transport or RCT) from the
cell surface of peripheral cells: (i) Apolipoprotein A1
(apoA1) interacts with ABCA1 and is the acceptor of
phosphatidylcholine efflux, which together with cholesterol
desorption results in the formation of HDL precursors in
serum (reviewed in ref 2 and 28). This unidirectional pathway
is energy-requiring, and other lipoproteins do not bind and/
or serve as effective acceptors (reviewed in ref 2). Interestingly, cross-linking studies of aortic endothelial cells after
HDL incubation have established direct interactions between
ABCA1 and both HDL and caveolin-1, but not HDL and
caveolin-1. This suggests that ABCA1 may act as a structural
platform between HDL and caveolin-1 on the cell surface
during cholesterol transfer to HDL (81). (ii) Serum HDL
tethered to SR-B1 facilitates cholesterol transfer from the
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plasma membrane in an energy-independent, bidirectional
process (2, 30). This pathway differs markedly from the
ABCA1 pathway in that SR-B1-mediated cholesterol transfer
is energy-independent, bidirectional, and less specific for only
one class of lipoprotein, i.e., HDLs (2, 30, 82-88). Whereas
binding of lipoproteins to the SR-B1 receptor appears to be
required for efficient cholesterol efflux, high-affinity binding
of the lipoprotein to the receptor is insufficient to account
for the observed relative order of cholesterol efflux (reviewed
in ref 2). For example, SR-B1 binds lipoproteins with the
following order of affinities: apoA1 > VLDL > HDL >
LDL (83, 88). In contrast, effectiveness in SR-B1-mediated
efflux of radiolabeled cholesterol from peripheral cells is in
the order HDL > VLDL, LDL (reviewed in refs 2, 83, and
88). The same approximate order of effectiveness was noted
in SR-B1-mediated uptake of fluorescent sterol measured by
real-time confocal imaging in living cells: HDL > LDL >
VLDL (89). Interestingly, however, regardless of the relative
affinities of SR-B1 for the respective lipoprotein classes or
their individual activities in mediating sterol efflux/uptake,
other lipoproteins do not effectively compete with HDL for
mediating RCT from intact peripheral cells (reviewed in ref
2, 83, 88, and 89). To further investigate the molecular
determinants of RCT from peripheral cells, studies were
designed to probe the effectiveness of the various lipoprotein
classes to act as acceptors (efflux) and donors (uptake) from/
to two different types of lipid rafts/caveolae and non-raft
preparations isolated from peripheral cell types (L-cell
fibroblasts, MDCK cells): (i) affinity chromatography (no
detergent, no high-pH carbonate buffer) was used to resolve
lipid rafts/caveolae and non-rafts from purified plasma
membranes; (ii) DRM and DSM were purified from cells
through the use of Triton X-100.
Caveolae represent only a subfraction of lipid rafts (9092). Consistent with this, the amount of protein found in
L-cell lipid rafts/caveolae and MDCK caveolae enriched
fractions represents a small percentage of the total protein
in plasma membrane, 10 and 2%, respectively, in keeping
with the results of others (93). Although ultrastructural
studies show that flask-shaped caveolae typically occupy
<10% of the cell surface in most cells, caveolin is found
not only in flask-shaped caveolae but also at or near the PM
in linear membrane patches or clustered invaginations (grapes
on a string) (90, 94). In addition, caveolin has been localized
at intracellular sites including intracellular transport/endocytic
vesicles and caveosomes (90, 94), endoplasmic reticulum and
trans Golgi network (94), and lipid droplets (95) and isolated
from the cytosol as soluble chaperone complexes (21, 96).
The lack of >2-fold enrichment of caveolin-1 from homogenate levels in the ConA-isolated L-cell lipid raft/caveolae
and MDCK caveolae fractions presented herein was thus in
keeping with the known presence of caveolin in locations
other than plasma membrane caveolaesthereby accounting
for the smaller enrichment of caveolin in ConA-purified
membranes. Furthermore, other known plasma membrane
lipid raft/caveolae markers (SR-B1 and GM1) were enriched
in the lipid rafts/caveolae and caveolae isolated by the
nondetergent ConA methodology. It is important to note that
even though caveolin is distributed to plasma membrane
locations other than plasma membrane caveolae, only the
cholesterol dynamics of lipid rafts/caveolae and caveolae
isolated by nondetergent methods were responsive to lipo-
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proteins (present work) and intracellular cholesterol transport
proteins such as SCP-2 (34, 49, 52). Finally, the structure
of lipid rafts/caveolae and caveolae isolated by nondetergent
methods differed markedly from that of the bulk plasma
membrane and non-rafts (34, 49, 52). Taken together, these
findings suggested that not only the presence of caveolin
but also structural properties of lipid rafts/caveolae and
caveolae contribute to a cholesterol membrane environment
responsive to extracellular lipoproteins and intracellular
cholesterol binding proteins. Thus, findings derived from
these studies contribute the following new insights:
First, lipid rafts/caveolae were enriched in lipids trafficked
through the RCT pathway. For example, the data presented
herein with lipid rafts/caveolae isolated by nondetergent, nonhigh-pH carbonate buffer, ConA affinity chromatography
were enriched in both cholesterol and phospholipid, confirming earlier studies with lipid rafts/caveolae isolated by ConA
affinity chromatography (34, 50, 51) or by other nondetergent, non-high-pH carbonate buffer-based methods (97-99).
However, because of preferential interaction of cholesterol
with sphingolipids and phospholipids with saturated acyl
chains, the caveolae/lipid rafts, caveolae, and lipid rafts are
selectively enriched in these raft-promoting lipids (i.e., SM,
GM1, phospholipids with saturated acyl chains) (10, 34, 5052, 74, 75, 97-105). In contrast, DRM exhibit much lower
phospholipid content arising from detergent-induced selective
loss of phospholipids, especially phosphatidylcholine, which
is the major plasma membrane phospholipid (97, 99, 106,
107). Thus, it is unlikely that DRM equate with lipid rafts/
caveolae isolated by nondetergent methods (92, 107). Finally,
lipid rafts/caveolae also contained low amounts of cholesteryl
ester and triacylglycerol. It is important to note that detection
of these lipids in lipid rafts/caveolae was not due to
contamination by adherent lipoproteins, which are especially
rich in cholesteryl ester and triacylglycerol. Western blotting
did not detect either apoB or apoA (protein components of
HDL, LDL, and VLDL) in lipid rafts/caveolae. Further
support for the presence of these lipids in lipid rafts/caveolae
comes from the finding that SR-B1 mediates selective uptake
not only of cholesterol but also of other lipids present in
lipoproteins including phospholipid, cholesteryl ester, and
triacylglycerol (2, 30, 82-88, 108). Thus, the lipid distribution within lipid rafts/caveolae was consistent with the
transient tethering of bound lipoproteins to SR-B1, which
may facilitate the transmembrane flux of these lipids
(reviewed in refs 2 and 109).
Second, it was shown for the first time that, despite being
more fluid than lipid rafts/caveolae and DRM (34, 49, 52),
the sterol exchange assays showed that non-rafts and DSM
were very poor sterol donors or acceptors to/from lipoproteins, regardless of lipoprotein class (HDL, apoA1, LDL,
VLDL) involved. This lack of responsiveness to extracellular
cholesterol transfer proteins (HDL, VLDL, LDL, apoA1) was
also observed with intracellular cholesterol transfer proteins
such as sterol carrier protein-2 (SCP-2) (34, 52). Sterol
exchange between non-rafts or DSM and lipoproteins was
likely poor/very slow because (i) lipoprotein receptors
mediating RCT (i.e., ABCA1, SR-B1, caveolin-1, P-gp) were
not enriched in non-rafts as shown herein and earlier
(reviewed in refs 1-4, 30, and 34-42). Likewise, DSM were
also not enriched in RCT proteins (reviewed in refs 3, 25,
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44-48, and 52). (ii) Neither caveolin-1, with which the
intracellular cholesterol transport protein SCP-2 directly
interacts at the cytofacial leaflet (5), nor SCP-2 (34) is
localized in non-rafts.
Third, sterol exchange assays indicated that lipid rafts/
caveolae and caveolae isolated from purified plasma membranes and DSM isolated from peripheral cell types (L-cell
fibroblasts, MDCK cells) were excellent sterol donors to
lipoproteins. This was consistent with lipid rafts/caveoale
and caveolae being enriched in RCT proteins (caveolin-1,
SR-B1, ABCA1, P-gp, ABCG1) known to induce the
formation of more aqueous-exposed, cholesterol oxidaseaccessible cholesterol in plasma membranes and/or in
cholesterol-rich microdomains (24, 83, 110-115). For
example, SRB1 increases the size of the membrane cholesterol pool available to cyclodextrin acceptors (116). Caveolin-1 and SR-B1, but not ABCA1 (117, 118), directly bind
cholesterol and/or are cross-linked by photoactivatable
cholesterol (4, 20, 21, 29, 117-120). However, it is important
to note that intracellular factors must also contribute to
cholesterol dynamics in lipid rafts/caveolae. For example,
the half-times of sterol exchange between lipid rafts/caveolae
donors and HDL acceptors shown herein were 2-3 h, and
the half-times of sterol exchange in the reverse direction,
i.e., uptake from HDL donors to purified lipid rafts/caveolae
acceptors, were even shorter, <2 h. However, these dynamics
were significantly slower than those observed with intact cells
exposed to lipoproteins that bind to SR-B1, i.e., on the order
of a few minutes (reviewed in refs 2 and 89). These data
suggest that translocation of sterol across the lipid rafts/
caveolae bilayer and efflux/uptake to bound HDL (or other
lipoproteins) may require participation of other processes or
additional intracellular factors present only in intact cell
which may include the ATP requiring translocases ABCA1
and P-gp. ABCA1 has been shown to be directly associated
with caveolin-1 (81). Incubation with anti-ABCA1 antibody
or the ABCA1 inhibitor BLT-1 both inhibited ABCA1mediated sterol flux to apoA1 (Figure 4). Although these
data suggest that ABCA1 induced a more rapidly exchangeable sterol pool even in the absence of ATP, nevertheless
this exchange was still slower than observed with intact cells.
Alternately, vesicular and/or protein-mediated cholesterol
transfer from intracellular sites to/from lipid rafts/caveolae
may affect sterol exchange since SCP-2 overexpression
inhibits HDL-mediated sterol efflux in fibroblasts (6).
Fourth, the lipoprotein specificity for sterol exchange with
lipid rafts/caveolae and/or DRM in Vitro suggested that LDL
and VLDL were better sterol acceptors, whereas apoA1 and
HDL were better sterol donors. Earlier studies also showed
that HDL depleted cholesterol from DRM, but comparative
studies with other lipoproteins were not reported (40). It
should be noted that the lipoprotein specificity presented
herein showing LDL and VLDL as the best sterol acceptors
from highly purified lipid rafts/caveolae in Vitro was opposite
from that observed in intact living cells, where HDL and
apoA1 are the best cholesterol acceptors from intact peripheral cell donors (reviewed in refs 2, 83, and 88). These
specificities in Vitro versus in intact cells were not correlated
with differences in respective binding affinities of SR-B1
for these lipoprotein classes (83, 88) or with differences in
cholesterol packing density among the different lipoprotein
acceptors (121, 122). Taken together, these results indicate
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that the specificity of cholesterol transfer to lipoproteins in
the serum is likely influenced by additional factors: (i)
Lipoproteins in serum compete for binding to the SR-B1
receptor. Surprisingly, despite the fact that SR-B1 binds LDL
and VLDL with similar or somewhat weaker affinities than
HDL, the lipoproteins do not compete with HDL for binding/
mediating RCT from intact peripheral cells (reviewed in refs
2, 83, 88, and 89). (ii) The energy requirement of the ABCA1
and P-gp transporters in ViVo and in intact cells correlates
with highest specificity of ABCA1-mediated sterol efflux
for apoA1 and pre-HDL (reviewed in ref 2). Since purified
lipid rafts/caveolae do not contain the energy production
machinery of the cell, the lack of ATP in these studies
performed with purified lipid rafts/caveolae in Vitro likely
contributes significantly to the reduced effectiveness of
apoA1 and possibly HDL as well. (iii) Intracellular factors
present only in intact cells may contribute to determining
sterol efflux patterns. Sterol transfer from intracellular sites
is mediated by both vesicular (caveolar vesicles, non-caveolar
vesicles) and protein-mediated (caveolin-1, SCP-2) pathways
that take different paths favoring the ABCA1 or the SR-B1
pathway (reviewed in refs 2, 3, 7, and 123). For example,
SCP-2 facilitates SR-B1-mediated molecular sterol efflux to
HDL, but concomitantly inhibits vesicular-mediated sterol
efflux to HDL in SCP-2 overexpressing fibroblastssthe latter
likely due to SCP-2’s affinity for ligands that regulate vesicle
budding from the Golgi (6).
Fifth, lipoproteins were excellent donors to lipid rafts/
caveolae in Vitro, in the order apoA1, HDL > VLDL, LDLs
consistent with the cholesterol packing densities in lipoproteins such as HDL and LDL, i.e., weaker in HDL and tighter
in LDL, that make HDL a better cholesterol donor (121, 122).
Finally, these studies with biochemically resolved distinct
plasma membrane fractionsscholesterol-poor non-rafts and
cholesterol-rich caveolae/lipid raftsswere not due to artifactual segregation of the plasma membrane into cholesterolrich and -poor regions during the isolation procedure (110,
124). Real-time multiphoton imaging of DHE in L-cell
fibroblasts established the existence of sterol-rich and sterolpoor domains in plasma membranes of living cells (31, 32,
125). Video imaging of DHE in HepG2 cells also confirmed
a nonrandom distribution of DHE in the plasma membrane
as evidenced by DHE highly clustered in microvilli (126).
Microvilli are sterol-rich microdomains or rafts, are present
in peripheral cell types as well as polarized cells, are highly
enriched in sterol (127, 128), and are enriched in ABC
transporters and SR-B1, both of which mediate cholesterol
transport (126, 129-131). In living cells, the size range of
sterol-rich domains, 200-565 nm (32), is generally smaller
than microvilli, 500-1000 nm (132-135). These findings
were confirmed by electron microscopy and immunofluorescence of fixed cells wherein cholesterol-rich domains were
detected with the noncytolytic perfringolysin O within
microvilli/filopodia (136). When cholesterol-rich lipid rafts
are disrupted, filipin indiscriminately labels all cholesterol
in the plasma membrane (136, 137). Thus, these data indicate
that cholesterol-rich rafts do exist in living cells and are not
a potential artifact of biochemical isolation procedures.
In summary, the data presented herein provided new
insights supporting the role of lipid rafts/caveolae in RCT:
(i) lipids known to be translocated through lipid rafts/
caveolae are enriched (cholesterol, phospholipid) and, in the
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case of lipids poorly soluble in bilayers (i.e., cholesteryl ester,
triacylglycerol), detectable in small amounts in lipid rafts/
caveolae; (ii) lipoprotein-mediated sterol uptake/efflux occurs
via lipid rafts/caveolae rather than non-rafts; and (iii) the
rate of lipoprotein specificity of sterol efflux from lipid rafts/
caveolae to lipoprotein acceptors in Vitro is slower and differs
in specificity from that in intact cells, where HDL and apoA1,
rather than LDL and VLDL, preferentially enhance sterol
efflux from intact peripheral cells (reviewed in refs 1, 2, 4,
6, 28, 35, 37, 38, 109, 124, and 138). These findings suggest
that additional factors (e.g., energy-driven cholesterol transbilayer translocation, intracellular vesicular transport, intracellular protein-mediated molecular cholesterol transport,
etc.) contribute significantly to regulating the direction of
sterol transfer between plasma membrane lipid rafts/caveolae
and serum lipoproteins/apoproteins.
REFERENCES
1. Fielding, P. E., and Fielding, C. J. (2002) Dynamics of lipoprotein
transport in the human circulatory system, in Biochemistry of
Lipids, Lipoproteins and Membranes (Vance, D. E., and Vance,
J., Eds.) 4th ed., pp 527-552, Elsevier, New York.
2. Yancey, P. G., Bortnick, A. E., Kellner-Weibel, G., de la LleraMoya, M., Phillips, M. C., and Rothblat, G. H. (2003) Importance
of different pathways of cellular cholesterol efflux, Arterioscler.
Thromb. Vasc. Biol. 23, 712-719.
3. Schroeder, F., Atshaves, B. P., Gallegos, A. M., McIntosh, A. L.,
Liu, J. C., Kier, A. B., Huang, H., and Ball, J. M. (2005) Lipid
rafts and caveolae organization, in AdVances in Molecular and
Cell Biology (Frank, P. G., and Lisanti, M. P., Eds.) pp 3-36,
Elsevier, Amsterdam, The Netherlands.
4. Smart, E. J. (2005) Caveolae and the regulation of cellular
cholesterol homeostasis, in AdVances in Molecular and Cell
Biology (Lisanti, M. P.. and Frank, P. G., Eds.) p 35, Elsevier,
Amsterdam, The Netherlands.
5. Zhou, M., Parr, R. D., Petrescu, A. D., Payne, H. R., Atshaves,
B. P., Kier, A. B., Ball, J. A., and Schroeder, F. (2004) Sterol
carrier protein-2 directly interacts with caveolin-1 in vitro and in
vivo, Biochemistry 43, 7288-7306.
6. Atshaves, B. P., Starodub, O., McIntosh, A. L., Roths, J. B., Kier,
A. B., and Schroeder, F. (2000) Sterol carrier protein-2 alters
HDL-mediated cholesterol efflux, J. Biol. Chem. 275, 3685236861.
7. Schroeder, F., Frolov, A., Schoer, J., Gallegos, A., Atshaves, B.
P., Stolowich, N. J., Scott, A. I., and Kier, A. B. (1998)
Intracellular sterol binding proteins, cholesterol transport and
membrane domains, in Intracellular Cholesterol Trafficking
(Chang, T. Y., and Freeman, D. A., Eds.) pp 213-234, Kluwer
Academic Publishers, Boston, MA.
8. Frolov, A., Cho, T. H., Billheimer, J. T., and Schroeder, F. (1996)
Sterol carrier protein-2, a new fatty acyl coenzyme A-binding
protein, J. Biol. Chem. 271, 31878-31884.
9. Schroeder, F., Zhou, M., Swaggerty, C. L., Atshaves, B. P.,
Petrescu, A. D., Storey, S., Martin, G. G., Huang, H., Helmkamp,
G. M., and Ball, J. M. (2003) Sterol carrier protein-2 functions in
phosphatidylinositol transfer and signaling, Biochemistry 42,
3189-3202.
10. Schroeder, F., Atshaves, B. P., McIntosh, A. L., Gallegos, A. M.,
Storey, S. M., Parr, R. D., Jefferson, J. R., Ball, J. M., and Kier,
A. B. (2007) Sterol carrier protein-2: new roles in regulating lipid
rafts and signaling, Biochim. Biophys. Acta (in press).
11. Pfanner, N., Glick, B. S., Arden, S. R., and Rothman, J. E. (1990)
Fatty acylation promotes fusion of transport vesicles with Golgi
cisternae, J. Cell Biol. 110, 955-961.
12. Pfanner, N., Orci, L., Glick, B. S., Amherdt, M., Arden, S. R.,
Malhotra, V., and Rothman, J. E. (1989) Fatty acyl CoA is required
for budding of transport vesicles from Golgi cisternae, Cell 59,
95-102.
13. Hale, J. E., and Schroeder, F. (1982) Asymmetric transbilayer
distribution of sterol across plasma membranes determined by
fluorescence quenching of dehydroergosterol, Eur. J. Biochem.
122, 649-661.

Biochemistry, Vol. 46, No. 48, 2007 13903
14. Sweet, W. D., and Schroeder, F. (1988) Polyunsaturated fatty acids
alter sterol transbilayer domains in LM fibroblast plasma membrane, FEBS Lett. 229, 188-192.
15. Kier, A. B., Sweet, W. D., Cowlen, M. S., and Schroeder, F. (1986)
Regulation of transbilayer distribution of a fluorescent sterol in
tumor cell plasma membranes, Biochim. Biophys. Acta 861, 287301.
16. Wood, W. G., Schroeder, F., Hogy, L., Rao, A. M., and Nemecz,
G. (1990) Asymmetric distribution of a fluorescent sterol in
synaptic plasma membranes: effects of chronic ethanol consumption, Biochim. Biophys. Acta 1025, 243-246.
17. Schroeder, F., Nemecz, G., Wood, W. G., Joiner, C., Morrot, G.,
Ayraut-Jarrier, M., and Devaux, P. F. (1991) Transmembrane
distribution of sterol in the human erythrocyte, Biochim. Biophys.
Acta 1066, 183-192.
18. Pitto, M., Brunner, J., Ferraretto, A., Ravasi, D., Palestini, P., and
Masserini, M. (2000) Use of a photoactivatable GM1 ganglioside
analogue to assess lipid distribution in caveolae bilayer, Glycoconjugate J. 17, 215-222.
19. Schroeder, F., and Nemecz, G. (1990) Transmembrane cholesterol
distribution, in AdVances in Cholesterol Research (Esfahami, M.,
and Swaney, J., Eds.) pp 47-87, Telford Press, Caldwell, NJ.
20. Murata, M., Peranen, J., Schreiner, R., Wieland, F., Kurzchalia,
T. V., and Simons, K. (1995) VIP21/caveolin is a cholesterolbinding protein, Proc. Natl. Acad. Sci. U.S.A. 92, 10339-10343.
21. Uittenbogaard, A., Ying, Y. S., and Smart, E. J. (1998) Characterization of a cytosolic heat-shock protein-caveolin chaperone
complex, J. Biol. Chem. 273, 6525-6532.
22. Fielding, P. E., Chau, P., Liu, D., Spencer, T. A., and Fielding,
C. J. (2004) Mechanism of platelet derived growth factor
dependent caveolin-1 phosphorylation: relationship to sterol
binding and the role of serine-80, Biochemistry 43, 2578-2586.
23. Fielding, P. E., Russell, J. S., Spencer, T. A., Hakamata, H., Nagao,
K., and Fielding, C. J. (2002) Sterol efflux to apolipprotein A-1
originates from caveolin-rich microdomains and potentiates PDGFdependent protein kinase activity, Biochemistry 41, 4929-4937.
24. Garrigues, A., Escargueil, A. E., and Orlowski, S. (2002) The
multidrug transporter, P-glycoprotein, actively mediates cholesterol
redistribution in the cell membrane, Proc. Natl. Acad. Sci. U.S.A.
99, 10347-10352.
25. Lavie, Y., and Liscovitch, M. (2000) Changes in lipid and protein
constituents of rafts and caveolae in multidrug resistant cancer
cells and their functional consequences, Glycoconjugate J. 17,
253-259.
26. Batetta, B., and Sanna, F. (2006) Cholesterol metabolism during
cell growth: which role for the plasma membrane, Eur. J. Lipid
Sci. Technol. 108, 687-699.
27. Daleke, D. L. (2007) Phospholipid flippases, J. Biol. Chem. 282,
821-825.
28. Schmitz, G., Kaminski, W. E., and Orso, E. (2000) ABC
transporters in cellular lipid trafficking, Curr. Opin. Lipidol. 11,
493-501.
29. Wang, N., Silver, D. L., Thiele, C., and Tall, A. R. (2001) ATPbinding cassette transporter A1 (ABCA1) functions as a cholesterol
efflux regulatory protein, J. Biol. Chem. 276, 23742-23747.
30. Matveev, S. V., Uittenbogaard, A., van der Westhuyzen, D. R.,
and Smart, E. J. (2001) Caveolin-1 negatively regulates SRB1
mediated selective uptake of high density lipoprotein-derived
cholesteryl ester, Eur. J. Biochem. 268, 5609-5616.
31. McIntosh, A., Gallegos, A., Atshaves, B. P., Storey, S., Kannoju,
D., and Schroeder, F. (2003) Fluorescence and multiphoton
imaging resolve unique structural forms of sterol in membranes
of living cells, J. Biol. Chem. 278, 6384-6403.
32. Zhang, W., McIntosh, A., Xu, H., Wu, D., Gruninger, T., Atshaves,
B. P., Liu, J. C. S., and Schroeder, F. (2005) Structural analysis
of sterol distribution in the plasma membrane of living cells,
Biochemistry 44, 2864-2984.
33. McIntosh, A., Atshaves, B. P., Huang, H., Gallegos, A. M., Kier,
A. B., Schroeder, F., Xu, H., Zhang, W., and Liu, S. (2006)
Multiphoton laser scanning microscopy and spatial analysis of
dehydroergosterol distributions on plasma membranes of living
cells, in Lipid Rafts (McIntosh, T., Ed.) Humana Press, Totowa,
NJ.
34. Atshaves, B. P., Gallegos, A., McIntosh, A. L., Kier, A. B., and
Schroeder, F. (2003) Sterol carrier protein-2 selectively alters lipid
composition and cholesterol dynamics of caveolae/lipid raft vs
non-raft domains in L-cell fibroblast plasma membranes, Biochemistry 42, 14583-14598.

13904 Biochemistry, Vol. 46, No. 48, 2007
35. Babitt, J., Trigatti, B., Rigotti, A., Smart, E. J., Anderson, R. G.
W., Xu, S., and Krieger, M. (1997) Murine SR-BI, a high density
lipoprotein receptor that mediates selective lipid uptake, is
N-Glycosylated and fatty acylated and colocalizes with plasma
membrane caveolae, J. Biol. Chem. 272, 13242-13249.
36. Mendez, A. J., Lin, G., Wade, D. P., Lawn, R. M., and Oram, J.
F. (2001) Membrane lipid domains distinct from cholesterol/
sphingomyelin-rich rafts are involved in the ABCA1-mediated
lipid secretory pathway, J. Biol. Chem. 276, 3158-3166.
37. Oram, J. F., and Lawn, R. M. (2001) ABCA1: the gatekeeper for
eliminating excess tissue cholesterol, J. Lipid Res. 42, 1173-1179.
38. Ioannou, Y. A. (2001) Multidrug permeases and subcellular
cholesterol transport, Mol. Cell. Biol. 2, 657-668.
39. Orso, E., Broccardo, C., Kaminski, W. E., Bottcher, A., Liebisch,
G., Drobnik, W., Gotz, A., Chambenoit, O., Diederich, W.,
Langmann, T., Spruss, T., Luciani, M.-F., Rothe, G., Lackner, K.
J., Chimini, G., and Schmitz, G. (2000) Transport of lipids from
Golgi to plasma membrane is defective in Tangier disease patients
and Abc1-deficient mice, Nat. Genet. 24, 192-196.
40. Drobnik, W., Borsukova, H., Bottcher, A., Pfeiffer, A., Liebisch,
G., Schutz, G. J., Schindler, H., and Schmitz, G. (2002) Apo AI/
ABCA1-dependent and HDL3-mediated lipid efflux from compositionally distinct cholesterol-based microdomains, Traffic 3,
268-278.
41. Ronaldson, P. T., Bendayan, M., Gingras, D., Piquette-Miller, M.,
and Bendayan, R. (2004) Cellular localization and functional
expression of P-glycoprotein in rat astrocyte cultures, J. Neurochem. 89, 788-800.
42. Jodoin, J., Demeule, M., Fenart, L., Cecchelli, R., Farmer, S.,
Linton, K. J., Higgins, C. F., and Beliveau, R. (2003) Pglycoprotein in blood-brain barrier endothelial cells: interaction
and oligomerization with caveolins, J. Neurochem. 87, 10101023.
43. Troost, J., Lindenmaier, H., Haefeli, W. E., and Weiss, J. (2004)
Modulation of cellular cholesterol alters P-glycoprotein activity
in multidrug-resistant cells, Mol. Pharmacol. 66, 1332-1339.
44. Kamau, S. W., Kramer, S. D., Gunthert, M., and WunderlichAllenspach, H. (2005) Effect of the modulation of the membrane
lipid composition on the localization and function of P-glycoprotein in MDR1-MDCK cells, In Vitro Cell DeV. Biol. 41, 207216.
45. Hinrichs, J. W. J., Klappe, K., Hummel, I., and Kok, J. W. (2004)
ATP-binding casette transporters are enriched in non-caveolar
detergent insoluble glycosphingolipid-enriched membrane domains
(DIGs) in human multidrug resistant cancer cells, J. Biol. Chem.
279, 5734-5738.
46. Luker, G. D., Pica, C. M., Kumar, A. S., Covey, D. F., and
Piwnica-Worms, D. (2000) Effect of cholesterol and enantiomeric
cholesterol on P-glycoprotein localization and function in low
density membrane domains, Biochemistry 39, 7651-7661.
47. Radeva, G., and Sharom, F. J. (2004) Isolation and characterization
of lipid rafts with different properteis from RBL-2H3 (rat
basophilic leukaemia) cells, Biochem. J. 380, 219-230.
48. Radeva, G., Perabo, J., and Sharom, F. J. (2005) P-glycoprotein
is localized in intermediate density membrane microdomains
distinct from classical lipid rafts and caveolar domains, FEBS J.
272, 4924-4937.
49. Gallegos, A. M., McIntosh, A. L., Atshaves, B. P., and Schroeder,
F. (2004) Structure and cholesterol domain dynamics of an
enriched caveolae/raft isolate, Biochem. J. 382, 451-461.
50. Atshaves, B. P., McIntosh, A. L., Payne, H. R., Gallegos, A. M.,
Landrock, K., Maeda, N., Kier, A. B., and Schroeder, F. (2007)
Sterol carrier protein-2/sterol carrier protein-x gene ablation alters
lipid raft domains in primary cultured mouse hepatocytes, J. Lipid
Res. 48, 2193-2211.
51. Atshaves, B. P., Jefferson, J. R., McIntosh, A. L., McCann, B.
M., Landrock, K., Kier, A. B., and Schroeder, F. (2007) Effect of
sterol carrier protein-2 expression on sphingolipid distribution in
L-cell fibroblast plasma membrane lipid rafts/caveolae, Lipids 42,
871-884.
52. Gallegos, A. M., Storey, S. M., Kier, A. B., Schroeder, F., and
Ball, J. M. (2006) Stucture and cholesterol dynamics of caveolae/
raft and nonraft plasma membrane domains, Biochemistry 45,
12100-12116.
53. Fischer, R. T., Stephenson, F. A., Shafiee, A., and Schroeder, F.
(1985) Structure and dynamic properties of dehydroergosterol,
delta 5,7,9(11),22-ergostatetraen-3 beta-ol, J. Biol. Phys. 13, 1324.

Storey et al.
54. Higuchi, K. (1970) An improved chemically defined culture
medium for strain L mouse cells based on growth responses to
graded levels of nutrients including iron and zinc, J. Cell Physiol.
75, 65-72.
55. Bradford, M. (1976) A rapid and sensitive method for the
quantitation of microgram quantities of protein utilizing the
principle of protein dye binding, Anal. Biochem. 72, 248-254.
56. Yeagle, P. L., Bensen, J., Greco, M., and Arena, C. (1982)
Cholesterol behavior in human serum lipoproteins, Biochemistry
21, 1249-1254.
57. Smutzer, G. (1988) A fluorescent sterol probe study of human
serum low density lipoproteins, Biochim. Biophys. Acta 958, 323333.
58. Colles, S. M., Wood, W. G., Myers-Payne, S. C., Igbavboa, U.,
Avdulov, N. A., Joseph, J., and Schroeder, F. (1995) Structure
and polarity of mouse brain synaptic plasma membrane: effects
of ethanol in Vitro and in ViVo, Biochemistry 34, 5945-5959.
59. Schroeder, F., Hubbell, T., Colles, S. M., and Wood, W. G. (1995)
Expression of liver fatty acid binding protein in L-cells: plasma
membrane response to ethanol, Arch. Biochem. Biophys. 316,
343-352.
60. Schroeder, F., Morrison, W. J., Gorka, C., and Wood, W. G. (1988)
Transbilayer effects of ethanol on fluidity of brain membrane
leaflets, Biochim. Biophys. Acta 946, 85-94.
61. Sweet, W. D., and Schroeder, F. (1986) Plasma membrane lipid
composition modulates action of anesthetics, Biochim. Biophys.
Acta 861, 53-61.
62. Sweet, W. D., Wood, W. G., and Schroeder, F. (1987) Charged
anesthetics selectively alter plasma membrane order, Biochemistry
26, 2828-2835.
63. Sweet, W. D., and Schroeder, F. (1986) Charged anaesthetics alter
LM-fibroblast plasma-membrane enzymes by selective fluidization
of inner or outer membrane leaflets, Biochem. J. 239, 301-310.
64. Gallegos, A. M., Atshaves, B. P., Storey, S. M., Starodub, O.,
Petrescu, A. D., Huang, H., McIntosh, A., Martin, G., Chao, H.,
Kier, A. B., and Schroeder, F. (2001) Gene structure, intracellular
localization, and functional roles of sterol carrier protein-2, Prog.
Lipid Res. 40, 498-563.
65. Schroeder, F. (1984) Fluorescent sterols: probe molecules of
membrane structure and function [review], Prog. Lipid Res. 23,
97-113.
66. Schroeder, F., Jefferson, J. R., Kier, A. B., Knittell, J., Scallen,
T. J., Wood, W. G., and Hapala, I. (1991) Membrane cholesterol
dynamics: cholesterol domains and kinetic pools, Proc. Soc. Exp.
Biol. Med. 196, 235-252.
67. Schroeder, F., Frolov, A. A., Murphy, E. J., Atshaves, B. P.,
Jefferson, J. R., Pu, L., Wood, W. G., Foxworth, W. B., and Kier,
A. B. (1996) Recent advances in membrane cholesterol domain
dynamics and intracellular cholesterol trafficking, Proc. Soc. Exp.
Biol. Med. 213, 150-177.
68. Delseth, C., Kashman, Y., and Djerassi, C. (1979) Ergosta-5,7,9(11),22-tetraen-3beta-ol and its 24epsilon-ethyl homolog, two new
marine sterols from the red sea sponge Biemna fortis, HelV. Chim.
Acta 62, 2037-2045.
69. Sica, D., Boniforti, L., and DiGiacomo, G. (1982) Sterols of
Candida tropicalis grown on n-alkanes, Phytochemistry 21, 234236.
70. Schroeder, F., Gallegos, A. M., Atshaves, B. P., Storey, S. M.,
McIntosh, A., Petrescu, A. D., Huang, H., Starodub, O., Chao,
H., Yang, H., Frolov, A., and Kier, A. B. (2001) Recent advances
in membrane cholesterol microdomains: rafts, caveolae, and
intracellular cholesterol trafficking, Exp. Biol. Med. 226, 873890.
71. Bergeron, R. J., and Scott, J. (1982) Fluorescent lipoprotein probe,
Anal. Chem. 119, 128-134.
72. Bergeron, R. J., and Scott, J. (1982) Cholestatriene and ergostatetraene as in vivo and in vitro membrane and lipoprotein probes, J.
Lipid Res. 23, 391-404.
73. Gimpl, G., and Fahrenholz, F. (2000) Human oxytocin receptors
in cholesterol-rich vs cholesterol-poor microdomains of the plasma
membrane. Eur. J. Biochem. 267, 2483-2497.
74. Gallegos, A. M., McIntosh, A. L., Kier, A. B., and Schroeder, F.
(2007) Membrane domain distributions: analysis of fluorescent
sterol exchange kinetics, Curr. Anal. Chem. (in press).
75. Duong, M., Collins, H. L., Jin, W., Zanotti, I., Favari, E., and
Rothblat, G. (2006) Relative contributions of ABCA1 and SR-BI
to cholesterol efflux to serum from fibroblasts and macrophages,
Arterioscler. Thromb. Vasc. Biol. 26, 541-547.

Sterol Dynamics between Lipoproteins and Caveolae
76. Gallegos, A. M., Atshaves, B. P., Storey, S., McIntosh, A.,
Petrescu, A. D., and Schroeder, F. (2001) Sterol carrier protein-2
expression alters plasma membrane lipid distribution and cholesterol dynamics, Biochemistry 40, 6493-6506.
77. Parton, R. G. (1994) Ultrastructural localization of gangliosides;
GM1 is concentrated in caveolae, J. Histochem. Cytochem. 42,
155-166.
78. Solis, G. P., Hoegg, M., Munderloh, C., Schrock, Y., MalagaTrillo, E., Rivera-Milla, E., and Stuermer, C. A. O. (2007) Reggie/
flotillin proteins are organized into stable tetramers in membrane
microdomains, Biochem. J. 403, 313-322.
79. Schroeder, F., Goh, E. H., and Heimberg, M. (1979) Regulation
of the surface physical properties of the very low density
lipoprotein, J. Biol. Chem. 254, 2456-2463.
80. Schroeder, F., Goh, E. H., and Heimberg, M. (1979) Investigation
of the surface structure of the very low density lipoprotein using
fluorescence probes, FEBS Lett. 97, 233-236.
81. Chao, W. T., Tsai, S.-H., Lin, Y.-C., Lin, W.-W., and Yang, V.
C. (2005) Cellular localization and interaction of ABCA1 and
caveolin-1 in aortic endothelial cells after HDL incubation,
Biochem. Biophys. Res. Commun. 332, 743-749.
82. Acton, S. L., Scherer, P. E., Lodish, H. F., and Krieger, M. (1994)
Expression cloning of SR-B1, a CD36-related class B scavenger
receptor, J. Biol. Chem. 269, 21003-21009.
83. de la Llera-Moya, M., Rothblat, G. H., Connelly, M. A., KellnerWeibel, G., Sakr, S. W., Phillips, M. C., and Williams, D. L.
(1999) Scavenger receptor B1 (SRB1) mediates free cholesterol
flux independently of HDL tethering to the surface, J. Lipid Res.
40, 575-580.
84. Gu, X., Kozarsky, K., and Krieger, M. (2000) Scavenger receptor
class B, type 1-mediated [3H]cholesterol efflux to high and low
density lipoproteins is dependent on lipoprotein binding to the
receptor, J. Biol. Chem. 275, 29993-30001.
85. de Beer, M. C., Durbin, D. M., Cai, L., Jonas, A., de Beer, F. C.,
and van der Westhuyzen, D. R. (2001) Apolipoprotein A1
conformation markedly influences HDL interaction with scavenger
receptor B1, J. Lipid Res. 42, 309-313.
86. Liadaki, K. N., Liu, T., Xu, S., Ishida, B. Y., Duchateaux, P. N.,
Krieger, J. P., Kane, J., Krieger, M., and Zannis, V. I. (2000)
Binding of high density lipoprotein (HDL) and discoidal reconstituted HDL to the HDL scavenger receptor class B type 1, J.
Biol. Chem. 275, 21262-21271.
87. Murao, K., Terpstra, V., Green, S. R., Kondratenko, N., Steinberg,
D., and Quehenberger, O. (1997) Characterization of CLA-1, a
human homologue of rodent scavenger receptor B1, as a receptor
for high density lipoprotein and apoptotic thymocytes, J. Biol.
Chem. 272, 17551-17557.
88. Calvo, M., Gomez-Coronado, D., Lasuncion, M. A., and Vega,
M. A. (1997) CLA-1 is an 85 kD plasma membrane glycoprotein
that acts as a high affinity receptor for both native (HDL, LDL,
and VLDL) and modified (OxLDL and AcLDL) lipoproteins,
Arterioscler. Thromb. Vasc. Biol. 17, 2341-2349.
89. Frolov, A., Petrescu, A., Atshaves, B. P., So, P. T. C., Gratton,
E., Serrero, G., and Schroeder, F. (2000) High density lipoprotein
mediated cholesterol uptake and targeting to lipid droplets in intact
L-cell fibroblasts, J. Biol. Chem. 275, 12769-12780.
90. Pike, L. J. (2003) Lipid rafts: bringing order to chaos, J. Lipid
Res. 44, 655-667.
91. Pike, L. J. (2004) Lipid rafts: heterogeneity on the high seas,
Biochem. J. 378, 281-292.
92. Pike, L. J. (2006) Rafts defined: a report on the Keystone
symposium on lipid rafts and cell function, J. Lipid Res. 47, 15971598.
93. Smart, E. J., Ying, Y., Mineo, C., and Anderson, R. G. W. (1995)
A detergent-free method for purifying caveolae membrane from
tissue culture cells, Proc. Natl. Acad. Sci. U.S.A. 92, 1040410408.
94. Anderson, R. (1998) The caveolae membrane system, Annu. ReV.
Biochem. 67, 199-225.
95. Fujimoto, T., Kogo, H., Ishiguro, K., Tauchi, K., and Nomura, R.
(2001) Caveolin-2 is targeted to lipid droplets, a new “membrane
domain” in the cell, J. Cell Biol. 152, 1079-1085.
96. Uittenbogaard, A., Everson, W. V., Matveev, S. V., and Smart,
E. J. (2002) Cholesteryl ester is transported from caveolae to
internal membranes as part of a caveolin-annexin II lipid-protein
complex, J. Biol. Chem. 277, 4925-4931.
97. Pike, L. J., Han, X., Chung, K.-N., and Gross, R. W. (2002) Lipid
rafts are enriched in arachidonic acid and plasmenylethanolamine
and their composition is independent of caveolin-1 expression: a

Biochemistry, Vol. 46, No. 48, 2007 13905
quantitative electrospray ionization/mass spectrometric analysis,
Biochemistry 41, 2075-2088.
98. Kirsch, C., Eckert, G. P., and Mueller, W. E. (2002) Statins affect
cholesterol micro-domains in brain plasma membranes, Biochem.
Pharmacol. 65, 843-856.
99. Eckert, G. P., Igbavboa, U., Muller, W., and Wood, W. G. (2003)
Lipid rafts of purified mouse brain synaptosomes prepared with
or without detergent reveal different lipid and protein domains,
Brain Res. 962, 144-150.
100. Storey, S. M., Gibbons, T. F., Williams, C. V., Parr, R. D.,
Schroeder, F., and Ball, J. M. (2007) Full-length, glycosylated
NSP4 is localized to plasma membrane caveolae by a novel raft
isolation technique, J. Virol. 81, 5472-5483.
101. Shaikh, S. R., Cherezov, V., Caffrey, M., Stillwell, W., and
Wassall, S. R. (2003) Interaction of cholesterol with a docosahexaenoic acid-containing phosphatidylethanolamine: trigger for
microdomain/raft formation?, Biochem. 42, 12028-12037.
102. Shaikh, S. R., Dumaual, A. C., Castillo, A., LoCascio, D., Siddiqui,
R. A., Stillwell, W., and Wassall, S. R. (2004) Oleic and
docosahexaenoic acid differentially phase separate from lipid raft
molecules: a comparative NMR, DSC, AFM, and detergent
extraction study, Biophys. J. 87, 1752-1766.
103. Siddiqui, R. A., Harvey, K. A., Zaloga, G. P., and Stillwell, W.
(2007) Modulation of lipid rafts by o-3 fatty acids in inflammation
and cancer: implications for use of lipids during nutrition support,
Nutr. Clin. Pract. 22, 74-88.
104. Fan, Y.-Y., Ly, L. H., Barhoumi, R., McMurray, D. N., and
Chapkin, R. S. (2004) Dietary docosahexaenoic acid suppresses
T cell protein kinase Ctheta lipid raft recruitment and IL-2
production, J. Immunol. 173, 6151-6160.
105. Ma, D. W. L., Seo, J., Switzer, K. C., Fan, Y.-Y., McMurray, D.
N., Lupton, J. R., and Chapkin, R. S. (2004) n-3 PUFA and
membrane microdomains: a new frontier in bioactive lipid
research, J. Nutr. Biochem. 15, 700-706.
106. Mazzone, A., Tietz, P., Jefferson, J. R., Pagano, R., and LaRusso,
N. F. (2006) Isolation and characterization of lipid microdomains
from apical and basolateral plasma membranes of rat hepatocytes,
Hepatology 43, 287-296.
107. Schuck, S., Honsho, M., Ekroos, K., Shevchenko, A., and Simons,
K. (2003) Resistance of cell membranes to different detergents,
Proc. Natl. Acad. Sci. U.S.A. 100, 5795-5800.
108. Thuahnai, S. T., Lund-Katz, S., Williams, D. L., and Phillips, M.
C. (2001) Scavenger receptor class B, type-1-mediated uptake of
various lipids into cells, J. Biol. Chem. 276, 43801-43808.
109. Fielding, C. J., and Fielding, P. E. (2001) Cellular cholesterol
efflux, Biochim. Biophys. Acta 1533, 175-189.
110. Smart, E. J., and van der Westhuyzen, D. R. (1998) Scavenger
receptors, caveolae, caveolin, and cholesterol trafficking, in
Intracellular Cholesterol Trafficking (Chang, T. Y., and Freeman,
D. A., Eds.) pp 253-272, Kluwer Academic Publishers, Boston,
MA.
111. Parathath, S., Connelly, M. A., Rieger, R. A., Klein, S. M.,
Abumrad, N. A., de la Llera-Moya, M., Iden, C. R., Rothblat, G.
H., and Williams, D. L. (2004) Changes in plasma membrane
properties and phosphatidylcholine subspecies of insect Sf9 cells
due to expression of scavenger receptor class B, type 1, and CD36,
J. Biol. Chem. 279, 41310-41318.
112. Vaughan, A. M., and Oram, J. F. (2003) J. Lipid Res. 44, 13731380.
113. Vaughan, A. M., and Oram, J. F. (2005) J. Biol. Chem. 280,
30150-30157.
114. Smart, E. J., Ying, Y. S., Conrad, P. A., and Anderson, R. G.
(1994) Caveolin moves from caveolae to the Golgi apparatus in
response to cholesterol oxidation, J. Cell Biol. 127, 1185-1197.
115. Baldan, A., Tarr, P., Lee, R., and Edwards, P. A. (2006) ATPbinding cassette transporter G1 and lipid homeostasis, Curr. Opin.
Lipidol. 17, 227-232.
116. Kellner-Weibel, G., de la Llera-Moya, M., Connelly, M. A., Stoudt,
G., Christian, A. E., Haynes, M. P., Williams, D. L., and Rothblat,
G. H. (2000) Expression of scavenger receptor Bl in COS-7 cells
alters cholesterol content and distribution, Biochemistry 39, 221229.
117. Wanaski, S., Ng, B. K., and Glaser, M. (2003) Caveolin scaffolding
region and the membrane binding region of Src form lateral
membrane domains, Biochemistry 42, 42-46.
118. Thiele, C., Hannah, M. J., Fahrenholz, F., and Huttner, W. B.
(2000) Cholesterol binds to synaptophysin and is required for
biogenesis of synaptic vesicles, Nat. Cell Biol. 2, 42-49.

13906 Biochemistry, Vol. 46, No. 48, 2007
119. Assanasen, C., Mineo, C., Seetharam, D., Yuhanna, I. S., Marcel,
Y. L., Connelly, M. A., Williams, D. L., de la Llera-Moya, M.,
Shaul, P. W., and Silver, D. L. (2005) Cholesterol binding, efflux,
and PDZ-interacting domain of scavenger receptor-B1 mediate
HDL-initiated signaling, J. Clin. InVest. 115, 969-977.
120. Roper, K., Corbeil, D., and Huttner, W. B. (2000) Retention of
prominin in microvilli reveals distinct cholesterol-based lipid
microdomains in the apical plasma membrane, Nat. Cell Biol. 2,
582-592.
121. Lund-Katz, S., and Phillips, M. C. (1986) Packing of cholesterol
molecules in human low density lipoprotein, Biochemistry 25,
1562-1568.
122. Lund-Katz, S., Hammerschlag, B., and Phillips, M. C. (1982)
Kinetics and mechanism of free cholesterol exchange between
human serum high- and low-density lipoproteins, Biochemistry
21, 2964-2969.
123. Soccio, R. E., and Breslow, J. L. (2004) Intracellular cholesterol
transport, Arterioscler. Thromb. Vasc. Biol. 24, 1150-1160.
124. Frank, P. G., Galbiati, F., Volonte, D., Razani, B., Cohen, D. E.,
Marcel, Y. L., and Lisanti, M. P. (2001) Influence of caveolin-1
on cellular cholesterol efflux mediated by high density lipoproteins, Am. J. Physiol. 280, C1204-C1214.
125. McIntosh, A. L., Atshaves, B. P., Huang, H., Gallegos, A. M.,
Kier, A. B., Schroeder, F., Xu, H., Zhang, W., and Liu, S. (2007)
Multiphoton laser scanning microscopy and spatial analysis of
dehydroergosterol distributions on plasma membrane of living
cells, in Lipid Rafts (McIntosh, T. J., Ed.) in press, Humana Press,
Totowa, NJ.
126. Wustner, D. (2005) Improved visualization and quantitative
analysis of fluorescent membrane sterol in polarized hepatic cells,
J. Microscopy 220, 47-64.
127. Sweet, W. D., and Schroeder, F. (1988) Lipid domains and enzyme
activity, in AdVances in Membrane Fluidity: Lipid Domains and
the Relationship to Membrane Function (Aloia, R. C., Cirtain, C.
C., and Gordon, L. M., Eds.) pp 17-42, Alan R. Liss, New York.
128. Kavecansky, J., Schroeder, F., and Joiner, C. H. (1995) Deoxygenation-induced alterations in sickle cell membrane cholesterol
exchange, Am. J. Physiol. 269, C1105-C1111.
129. Sehayek, E., Wang, R., Ono, J. G., Zinchuck, V. S., Duncan, E.
M., Shefer, S., Vance, D. E., Ananthanarayanan, M., Chait, B.
T., and Breslow, J. L. (2003) Localization of the PE methylation
pathway and SR-B1 to the canalicular membrane: evidence for
apical PC biosynthesis that may promote biliary excretion of
phospholipid and cholesterol, J. Lipid Res. 44, 1605-1613.

Storey et al.
130. Peng, Y., Akmentin, W., Conneely, M. A., Lund-Katz, S., Phillips,
M. C., and Williams, D. L. (2003) Scavenger receptor B1 (SRB1) clustered on microvillar extensions suggests that this plasma
membrane domain is a way station for cholesterol trafficking
between cells and high density lipoprotein, Mol. Biol. Cell 15,
384-396.
131. Reaven, E., Leers-Sucheta, S., Nomoto, A., and Azhar, S. (2001)
Expression of scavenger receptor class B type 1 (SR-B1) promotes
microvillar channel formation and selective cholesteryl ester
transport in a heterologous reconstituted system, Proc. Natl. Acad.
Sci. U.S.A. 98, 1613-1618.
132. Schroeder, F., Fontaine, R. N., and Kinden, D. A. (1982) LM
fibroblast plasma membrane subfractionation by affinity chromatography on ConA-sepharose, Biochim. Biophys. Acta 690, 231242.
133. Schroeder, F., and Kinden, D. A. (1983) Measurement of phagocytosis using fluorescent latex beads, J. Biochem. Biophys.
Methods 8, 15-27.
134. Yonemura, S., Tsukita, S., and Tsukita, S. (1999) Direct involvement of ezrin/radixin/moesin (ERM)-binding membrane proteins
in the organization of microvilli in collaboration with activated
ERM proteins, J. Cell Biol. 145, 1497-1509.
135. Corbeil, D., Roper, K., Hannah, M. J., Hellwig, A., and Huttner,
W. B. (1999) Selective localization of the polytopic membrane
protein prominin in microvilli of ephithelial cellssa combinationof
apical sorting and retention in plasma membrane protrusions, J.
Cell Sci. 112, 1023-1033.
136. Mobius, W., Ohno-Iwashita, Y., van Donselaar, E., Oorschot, V.
M. J., Shimada, Y., Fujimoto, T., Heijnen, H. F. G., Geuze, H. J.,
and Slot, J. W. (2002) Immunoelectron microscopic localization
of cholesterol using biotinylated and non-cytolytic perfringolysin
O, J. Histochem. Cytochem. 50, 43-55.
137. Waheed, A. A., Shimada, Y., Heijnen, H. F. G., Nakamura, M.,
Inomata, M., Hayashi, M., Iwashita, S., Slot, J. W., and OhnoIwashita, Y. (2001) Selective binding of perfringolysin O derivative to cholesterol-rich membrane microdomains (rafts), Proc.
Natl. Acad. Sci. U.S.A. 98, 4926-4931.
138. Everson, W. V., and and Smart, E. J. (2005) Caveolae and the
regulation of cellular cholesterol homeostasis, in CaVeolae and
Lipid Rafts: Roles in Signal Transduction and the Pathogenesis
of Human Disease (Lisanti, M. P., and Frank, P. G., Eds.) pp
37-55, Elsevier Academic Press, San Diego, CA.
BI700690S

